Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Valvular Heart Disease

  Free Subscription


Articles published in Catheter Cardiovasc Interv

Retrieve available abstracts of 435 articles:
HTML format



Single Articles


    May 2022
  1. SIMARD T, Reddy YNV, Thaden JJ, Padang R, et al
    Atrial mitral regurgitation: Characteristics and outcomes of transcatheter mitral valve edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022 May 10. doi: 10.1002/ccd.30224.
    PubMed     Abstract available


    April 2022
  2. BRUNO F, Elia E, D'Ascenzo F, Marengo G, et al
    Valve-in-valve transcatheter aortic valve replacement or re-surgical aortic valve replacement in degenerated bioprostheses: A systematic review and meta-analysis of short and midterm results.
    Catheter Cardiovasc Interv. 2022 Apr 29. doi: 10.1002/ccd.30219.
    PubMed     Abstract available


  3. MEMON MM, Siddiqui AA, Amin E, Shaikh FN, et al
    Novel oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Apr 27. doi: 10.1002/ccd.30213.
    PubMed     Abstract available


  4. KAWAGUCHI T, Miyoshi T, Hayashi M, Ishizu K, et al
    Efficacy of larger valve sizing with underfilling in balloon-expandable transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30188.
    PubMed     Abstract available


  5. HOLLOWED J, Akhondi A, Rabbani A, Oncel D, et al
    Single versus double Perclose techniques for vascular closure during transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30176.
    PubMed     Abstract available


  6. HOU S, Pan W, Zhou D, Ge J, et al
    Percutaneous balloon mitral valvuloplasty using veno-arterial loop and neuro-embolic protection for mitral stenosis with thrombus.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30203.
    PubMed     Abstract available


  7. PIRIOU PG, Manigold T, Letocart V, Le Ruz R, et al
    Outcomes of emergency transcatheter aortic valve replacement in patients with cardiogenic shock: A multicenter retrospective study.
    Catheter Cardiovasc Interv. 2022 Apr 8. doi: 10.1002/ccd.30194.
    PubMed     Abstract available


  8. YONG CM, Jaluba K, Batchelor W, Gummipundi S, et al
    Temporal trends in transcatheter aortic valve replacement use and outcomes by race, ethnicity, and sex.
    Catheter Cardiovasc Interv. 2022 Apr 8. doi: 10.1002/ccd.30182.
    PubMed     Abstract available


  9. ENG MH, Fang HK
    TMVR: Early benefits, late questions.
    Catheter Cardiovasc Interv. 2022;99:1666-1667.
    PubMed    


  10. INCI E, Block PC
    A little leak goes a long way! 5-Year-outcome after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022;99:1590-1591.
    PubMed     Abstract available


  11. LIU X, Chen Y, Lim DS, Wang J, et al
    Transcatheter mitral valve repair in patient with atrial functional mitral regurgitation using novel DragonFly device.
    Catheter Cardiovasc Interv. 2022;99:1691-1695.
    PubMed     Abstract available


  12. TARANTINI G, Rodino G
    Transcatheter aortic valve replacement for native and prosthetic aortic regurgitation: Two birds with one stone.
    Catheter Cardiovasc Interv. 2022;99:1609-1610.
    PubMed    


  13. BRUCE CG, Lederman RJ
    Troubleshooting transcaval access: Honoring our commitments.
    Catheter Cardiovasc Interv. 2022;99:1700-1701.
    PubMed    


  14. BANSAL A, Jaber WA, Reed GW, Puri R, et al
    Surgical versus medical management of infective endocarditis after TAVR.
    Catheter Cardiovasc Interv. 2022;99:1592-1596.
    PubMed     Abstract available


  15. RUGE H, Burri M, Erlebach M, Lange R, et al
    Propensity matched analysis of vascular complications using integrated or expandable sheaths for TAVR.
    Catheter Cardiovasc Interv. 2022;99:1611-1618.
    PubMed     Abstract available


  16. SEGAR MW, Krajcer Z
    Sex-based differences in patients undergoing transseptal transcatheter mitral valve replacement: Closing the sex disparity gap.
    Catheter Cardiovasc Interv. 2022;99:1645-1646.
    PubMed    


  17. GOLDSWEIG AM, Hermiller JB
    Endocarditis following transcatheter or surgical aortic valve replacement: What's the difference?
    Catheter Cardiovasc Interv. 2022;99:1597-1598.
    PubMed    


    March 2022
  18. ZHU Q, Yuan Z, Xu Y, Chen J, et al
    Validation of a novel staging classification system based on the extent of cardiac damage among Chinese patients after transcatheter aortic valve replacement: A single-center retrospective study.
    Catheter Cardiovasc Interv. 2022 Mar 24. doi: 10.1002/ccd.30147.
    PubMed     Abstract available


  19. LE RUZ R, Guerin P, Leurent G, Leroux L, et al
    Mitral valve-in-valve and valve-in-ring procedures: Midterm outcomes in a French nationwide registry.
    Catheter Cardiovasc Interv. 2022 Mar 24. doi: 10.1002/ccd.30161.
    PubMed     Abstract available


  20. ROTTLANDER D, Golabkesh M, Degen H, Ogutcu A, et al
    Mitral valve edge-to-edge repair versus indirect mitral valve annuloplasty in atrial functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30157.
    PubMed     Abstract available


  21. ESCHENBACH LK, Erlebach M, Deutsch MA, Ruge H, et al
    Stroke after transcatheter aortic valve replacement: A severe complication with low predictability.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30143.
    PubMed     Abstract available


  22. SA MP, Jabagi H, Dokollari A, Awad AK, et al
    Early and late outcomes of surgical aortic valve replacement with sutureless and rapid-deployment valves versus transcatheter aortic valve implantation: Meta-analysis with reconstructed time-to-event data of matched studies.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30162.
    PubMed     Abstract available


  23. ABUMEHDI M, Mehta C, Afifi ARSA, Yong SF, et al
    Supravalvular pulmonary stenosis: A risk factor for reintervention in Noonan syndrome with pulmonary valve stenosis.
    Catheter Cardiovasc Interv. 2022 Mar 9. doi: 10.1002/ccd.30148.
    PubMed     Abstract available


  24. MANO TB, Ramos R, Cacela D, Patricio L, et al
    Not all pseudoaneurysms are femoral-A transcaval transcatheter aortic valve replacement rare complication.
    Catheter Cardiovasc Interv. 2022 Mar 3. doi: 10.1002/ccd.30140.
    PubMed     Abstract available


  25. GILANI S, Jneid H
    Reaching the optimal volume-quality balance in transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;99:1186-1187.
    PubMed    


  26. ENG MH, Fang HK
    Forgotten and unforgiving.
    Catheter Cardiovasc Interv. 2022;99:1287-1288.
    PubMed    


  27. SIMPSON TF, Kheiri B, Chadderdon S, Song HK, et al
    TAVR operator volumes, trends, and geographic variations amongst Medicare beneficiaries in the United States.
    Catheter Cardiovasc Interv. 2022;99:1181-1185.
    PubMed     Abstract available


  28. FABRY N, Hendrickson MJ, Arora S, Vavalle JP, et al
    Five-year trends in cause-specific readmissions and cost burden of mitral transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2022;99:1251-1256.
    PubMed     Abstract available


  29. RANARD LS, Vahl TP, Chung CJ, Sadri S, et al
    Impact of inferior vena cava entry characteristics on tricuspid annular access during transcatheter interventions.
    Catheter Cardiovasc Interv. 2022;99:1268-1276.
    PubMed     Abstract available


  30. KANG SL, Ramroop R, Manojlovich L, Runeckles K, et al
    Is there a role for endovascular stent implantation in the management of postoperative right ventricular outflow tract obstruction in the era of transcatheter valve implantation?
    Catheter Cardiovasc Interv. 2022;99:1138-1148.
    PubMed     Abstract available


  31. ADAMSON GT, Peng LF, Perry SB, Hanley FL, et al
    Comprehensive diagnostic catheterization in children with major aortopulmonary collateral arteries: A review of catheterization technique and anatomic nomenclature.
    Catheter Cardiovasc Interv. 2022;99:1129-1137.
    PubMed     Abstract available


  32. ABUSHOUK AI, Saad AM, Isogai T, Shekhar S, et al
    Long-term outcomes of transcatheter valve-in-valve replacement for failed aortic bioprosthesis: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1370-1372.
    PubMed    


    February 2022
  33. ASAMI M, Dobner S, Stortecky S, Heg D, et al
    Cardiovascular outcomes in patients with left atrial enlargement undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2022 Feb 16. doi: 10.1002/ccd.30132.
    PubMed     Abstract available


  34. ELBADAWI A, Tan BE, Sammour Y, Saad M, et al
    Sex-related differences in the trends and outcomes of trans-septal transcatheter mitral valve replacement: Insights from the National Readmissions Database.
    Catheter Cardiovasc Interv. 2022 Feb 7. doi: 10.1002/ccd.30072.
    PubMed     Abstract available


  35. VALVO R, Costa G, Tamburino C, Barbanti M, et al
    Usefulness of intravascular ultrasound to assess coronary occlusion after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Feb 3. doi: 10.1002/ccd.30116.
    PubMed     Abstract available


  36. BRUNNER S, Wolfrum M, Moccetti F, Stampfli SF, et al
    The relevance of tricuspid regurgitation in patients undergoing percutaneous treatment of mitral regurgitation.
    Catheter Cardiovasc Interv. 2022 Feb 3. doi: 10.1002/ccd.30114.
    PubMed     Abstract available


  37. POSTALIAN A, Krajcer Z
    Facilitating future access to the coronary arteries in patients who need transcatheter aortic valve replacement: A significant step in the right direction.
    Catheter Cardiovasc Interv. 2022;99:932-933.
    PubMed    


  38. GOLDSWEIG AM, Baron SJ
    Prosthetic valve endocarditis: Literally a growing concern following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;99:904-905.
    PubMed     Abstract available


  39. UPADHYAY A, Jneid H
    Predischarge transthoracic echocardiogram after TAVI - Is it really necessary?
    Catheter Cardiovasc Interv. 2022;99:867-868.
    PubMed    


  40. O'NEILL BP, Wang DD, Caranasos TG, Chitwood WR Jr, et al
    Initial in-human experience with the conveyor cardiovascular system for the delivery of large profile transcatheter valve devices.
    Catheter Cardiovasc Interv. 2022;99:943-948.
    PubMed     Abstract available


  41. WELLE GA, El-Sabawi B, Thaden JJ, Greason KL, et al
    Effect of eliminating pre-discharge transthoracic echocardiogram on outcomes after TAVR.
    Catheter Cardiovasc Interv. 2022;99:861-866.
    PubMed     Abstract available


    January 2022
  42. ZHOU D, Chen J, Fan J, Yidilisi A, et al
    Self-expanding transcatheter aortic valve replacement in patients with extremely horizontal aortas.
    Catheter Cardiovasc Interv. 2022 Jan 30. doi: 10.1002/ccd.30094.
    PubMed     Abstract available


  43. OGAMI T, Kurlansky P, Takayama H, Ning Y, et al
    Three-year survival of transcatheter versus surgical aortic valve replacement in dialysis.
    Catheter Cardiovasc Interv. 2022 Jan 27. doi: 10.1002/ccd.30045.
    PubMed     Abstract available


  44. PAULUS MG, Meindl C, Hamerle M, Schach C, et al
    Reduction of radiation exposure during transcatheter edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2022 Jan 27. doi: 10.1002/ccd.30046.
    PubMed     Abstract available


  45. LAWLOR MK, Hamid N, Kampaktsis P, Ning Y, et al
    Incidence and predictors of cardiogenic shock following surgical or transcatheter tricuspid valve intervention.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30073.
    PubMed     Abstract available


  46. KATO N, Pellikka PA, Scott CG, Lee AT, et al
    Impact of mitral intervention on outcomes of patients with mitral valve dysfunction and annulus calcification.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30093.
    PubMed     Abstract available


  47. SCHOECHLIN S, Hein M, Brennemann T, Eichenlaub M, et al
    5-Year outcomes after transcatheter aortic valve implantation: Focus on paravalvular leakage assessed by echocardiography and hemodynamic parameters.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30083.
    PubMed     Abstract available


  48. FREIXA X, Estevez-Loureiro R, Pascual I, Carrasco-Chinchilla F, et al
    Procedural and clinical outcomes after repeat edge-to-edge transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30053.
    PubMed     Abstract available


  49. PARAGGIO L, Burzotta F, Graziani F, Aurigemma C, et al
    Transcatheter aortic valve implantation in pure aortic regurgitation: Hemodynamic and echocardiographic findings in bioprosthesis vs. native valve.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30082.
    PubMed     Abstract available


  50. ADAMO M, Pagnesi M, Popolo Rubbio A, Branca L, et al
    Predictors of optimal procedural result after transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation.
    Catheter Cardiovasc Interv. 2022 Jan 15. doi: 10.1002/ccd.30062.
    PubMed     Abstract available


  51. SIMARD T, Lloyd J, Crestanello J, Thaden JJ, et al
    Five-year outcomes of transcatheter mitral valve implantation and redo surgery for mitral prosthesis degeneration.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30059.
    PubMed     Abstract available


  52. CHIOU A, Yap J, Russo S, Stripe BR, et al
    Understanding repeat hospitalizations in intermediate-to-high risk aortic stenosis patients following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30066.
    PubMed     Abstract available


  53. CAJIGAS HR, Kaptzan T, Lewis B, El-Sabbagh A, et al
    The impact of pulmonary hypertension on outcomes of transcatheter mitral valve replacement in mitral annular calcification.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30057.
    PubMed     Abstract available


  54. INCI E, Block PC
    Transcatheter valve in valve replacement in stentless prosthetic aortic valves compared to a surgical approach: The lunch is good, but not free!
    Catheter Cardiovasc Interv. 2022;99:193-194.
    PubMed    


  55. OKUYA Y, Moussa ID
    Surgical bailout after transcatheter aortic valve replacement: Hospital procedural volume matters!
    Catheter Cardiovasc Interv. 2022;99:169-170.
    PubMed    


  56. BELARDI J, Lamelas P
    Serious adverse events related to transcatheter aortic valve replacement are infrequent: FORWARD 3-years.
    Catheter Cardiovasc Interv. 2022;99:179-180.
    PubMed    


  57. UPADHYAY A, Jneid H
    Frailty and malnutrition as influential drivers of outcomes after aortic valve replacement.
    Catheter Cardiovasc Interv. 2022;99:158-159.
    PubMed    


  58. RODRIGUEZ OGANDO A, Ballesteros F, Martinez JLZ
    Pulmonary percutaneous valve implantation in large native right ventricular outflow tract with 32 mm Myval transcatheter heart valve.
    Catheter Cardiovasc Interv. 2022;99:E38-E42.
    PubMed     Abstract available


    December 2021
  59. POPOLO RUBBIO A, Testa L, Granata G, Salvatore T, et al
    Prognostic significance of right ventricle to pulmonary artery coupling in patients with mitral regurgitation treated with the MitraClip system.
    Catheter Cardiovasc Interv. 2021 Dec 23. doi: 10.1002/ccd.30044.
    PubMed     Abstract available


  60. VOGL BJ, Darestani YM, Lilly SM, Thourani VH, et al
    Impact of blood pressure on coronary perfusion and valvular hemodynamics after aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Dec 22. doi: 10.1002/ccd.30052.
    PubMed     Abstract available


  61. OKOH AK, Chen C, Kassotis J, Soliman F, et al
    Utilizing ambulatory electrocardiogram monitoring to reduce conduction related death after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Dec 1. doi: 10.1002/ccd.30027.
    PubMed     Abstract available


  62. MOUSSA ID
    Prediction of left circumflex artery impingement after indirect mitral annuloplasty with the carillon device: "There is more to this than meets the eye!"
    Catheter Cardiovasc Interv. 2021;98:1402-1403.
    PubMed    


  63. SAIA F
    Transcatheter edge-to-edge mitral valve repair: Should we stay tied to COAPT tiers?
    Catheter Cardiovasc Interv. 2021;98:1413-1414.
    PubMed    


  64. SCHNEIDER LM, Nicoleta N, Schepperle N, Paukovitsch M, et al
    Implications of concomitant obstructive or restrictive pulmonary diseases on functional and clinical results after MitraClip.
    Catheter Cardiovasc Interv. 2021;98:E1000-E1006.
    PubMed     Abstract available


    November 2021
  65. WANG DD, O'Neill BP, Caranasos TG, Chitwood WR Jr, et al
    Comparative differences of mitral valve-in-valve implantation: A new mitral bioprosthesis versus current mosaic and epic valves.
    Catheter Cardiovasc Interv. 2021 Nov 29. doi: 10.1002/ccd.30011.
    PubMed     Abstract available


  66. HOKKEN TW, de Ronde M, Wolff Q, Schermers T, et al
    Insights in a restricted temporary pacemaker strategy in a lean transcatheter aortic valve implantation program.
    Catheter Cardiovasc Interv. 2021 Nov 27. doi: 10.1002/ccd.30026.
    PubMed     Abstract available


  67. GUNARATHNE A, Tan J, Varcoe R, Bhandari S, et al
    The impact of learning-curve-experience on transcatheter aortic valve replacement outcomes: Insights from the United Kingdom and Ireland all-comers second-generation ACURATE neo transcatheter aortic heart valve registry.
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30000.
    PubMed     Abstract available


  68. DAS TM, Shin J, Czarny MJ, Nanavati J, et al
    Radial versus femoral secondary access for transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30009.
    PubMed     Abstract available


  69. NEUSER J, Kempf T, Bauersachs J, Widder JD, et al
    Novel self-expanding ALLEGRA transcatheter aortic valve for native aortic stenosis and degenerated bioprosthesis.
    Catheter Cardiovasc Interv. 2021 Nov 17. doi: 10.1002/ccd.30003.
    PubMed     Abstract available


  70. WOLFRUM M, Moccetti F, Piuhola J, Lehtola H, et al
    The Allegra transcatheter heart valve: Short term results from a multicenter registry.
    Catheter Cardiovasc Interv. 2021;98:1204-1209.
    PubMed     Abstract available


  71. ENG MH, Abbas AE, Hahn RT, Lee J, et al
    Real world outcomes using 20 mm balloon expandable SAPIEN 3/ultra valves compared to larger valves (23, 26, and 29 mm)-a propensity matched analysis.
    Catheter Cardiovasc Interv. 2021;98:1185-1192.
    PubMed     Abstract available


  72. ORVIN K, Perl L, Landes U, Dvir D, et al
    Percutaneous mechanical circulatory support from the collaborative multicenter Mechanical Unusual Support in TAVI (MUST) Registry.
    Catheter Cardiovasc Interv. 2021;98:E862-E869.
    PubMed     Abstract available


  73. DE MARCO F, Casenghi M, Spagnolo P, Popolo Rubbio A, et al
    A patient-specific algorithm to achieve commissural alignment with Acurate Neo: The sextant technique.
    Catheter Cardiovasc Interv. 2021;98:E847-E854.
    PubMed     Abstract available


  74. RAZUK V, Camaj A, Cao D, Nicolas J, et al
    Impact of anemia on short-term outcomes after TAVR: A subgroup analysis from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2021;98:E870-E880.
    PubMed     Abstract available


  75. HAMMAD TA, Abu-Omar Y, Shishehbor MH
    Novel intracardiac echocardiography-guided catheter-based removal of inoperable tricuspid valve vegetation.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.29999.
    PubMed     Abstract available


  76. BAGUR R, Jneid H
    Coronary artery access after aortic valve intervention.
    Catheter Cardiovasc Interv. 2021;98:957-958.
    PubMed    


  77. REILLY JP, Parikh PB
    Valve-in-valve transcatheter aortic valve replacement versus re-do surgical aortic valve replacement: A call for randomized controlled trials.
    Catheter Cardiovasc Interv. 2021;98:948-949.
    PubMed    


  78. ARSLAN F, Gerckens U
    Virtual support for remote proctoring in TAVR during COVID-19.
    Catheter Cardiovasc Interv. 2021;98:E733-E736.
    PubMed     Abstract available


  79. KIM JY, Kim SH, Jang SI
    Bilateral branch pulmonary artery Pulsta valve implantation for treatment of large right ventricular outflow tract in a high-risk patient.
    Catheter Cardiovasc Interv. 2021;98:923-927.
    PubMed     Abstract available


  80. KAPLE RK, Agarwal V, Azarbal A, Sugeng L, et al
    Tricuspid clip implantation using the MitraClip system-A step-by-step guide.
    Catheter Cardiovasc Interv. 2021;98:1006-1019.
    PubMed     Abstract available


    October 2021
  81. AMIN R, Arunothayaraj S, Kirtchuk D, Williams T, et al
    Mobility aids predict mortality after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Oct 22. doi: 10.1002/ccd.29981.
    PubMed     Abstract available


  82. STANOVA V, Rieu R, Cote N, Salaun E, et al
    In vitro Doppler versus catheter transvalvular pressure gradients in balloon-expandable versus self-expanding transcatheter aortic valves.
    Catheter Cardiovasc Interv. 2021 Oct 11. doi: 10.1002/ccd.29974.
    PubMed     Abstract available


  83. TANG GHL, Sengupta A, Alexis SL, Zaid S, et al
    Conventional versus modified delivery system technique in commissural alignment from the Evolut low-risk CT substudy.
    Catheter Cardiovasc Interv. 2021 Oct 9. doi: 10.1002/ccd.29973.
    PubMed     Abstract available


  84. MATSUMOTO S, Ohno Y, Miyamoto J, Ikari Y, et al
    Impact of diabetes mellitus on outcome after transcatheter aortic valve replacement: Identifying high-risk diabetic population from the OCEAN-TAVI registry.
    Catheter Cardiovasc Interv. 2021 Oct 6. doi: 10.1002/ccd.29960.
    PubMed     Abstract available


  85. MUSUMECI G, Annibali G
    Transcarotid access as a first alternative approach to transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021;98:774-775.
    PubMed    


  86. OKUYA Y, Moussa ID
    Hemolysis after transcatheter mitral valve replacement: An underreported phenomenon!
    Catheter Cardiovasc Interv. 2021;98:786-787.
    PubMed    


  87. TARANTINI G, Scotti A
    Bioprosthetic valve fracture for aortic valve-in-valve procedures: Handle with care-extra weapon.
    Catheter Cardiovasc Interv. 2021;98:765-766.
    PubMed    


  88. BRINKMANN C, Abdel-Wahab M, Bedogni F, Bhadra OD, et al
    Bioprosthetic valve fracture: Predictors of outcome and follow-up. Results from a multicenter study.
    Catheter Cardiovasc Interv. 2021;98:756-764.
    PubMed     Abstract available


  89. GARCIA-SAYAN E, Raghunathan D, Li FM, Dhoble A, et al
    Initial experience with the fourth generation MitraClip: Outcomes, procedural aspects, and considerations for device selection.
    Catheter Cardiovasc Interv. 2021;98:E626-E636.
    PubMed     Abstract available


  90. SUGIURA A, Weber M, Tabata N, Goto T, et al
    QRS duration is a risk indicator of adverse outcomes after MitraClip.
    Catheter Cardiovasc Interv. 2021;98:E594-E601.
    PubMed     Abstract available


    September 2021
  91. ELBADAWI A, Mahta D, Elgendy IY, Dang AT, et al
    Trends in utilization, outcomes, and readmissions after transcatheter mitral valve replacement.
    Catheter Cardiovasc Interv. 2021 Sep 27. doi: 10.1002/ccd.29963.
    PubMed     Abstract available


  92. LEE DU, Han J, Fan GH, Hastie DJ, et al
    The clinical impact of chronic liver disease in patients undergoing transcatheter and surgical aortic valve replacement: Systematic analysis of the 2011-2017 US hospital database.
    Catheter Cardiovasc Interv. 2021 Sep 25. doi: 10.1002/ccd.29952.
    PubMed     Abstract available


  93. MAISANO F, Russo G, Tagliari AP, Gavazzoni M, et al
    Left femoral vein access for transcatheter mitral valve interventions in unfavorable interatrial septal anatomy.
    Catheter Cardiovasc Interv. 2021 Sep 17. doi: 10.1002/ccd.29950.
    PubMed     Abstract available


  94. ATTIZZANI GF, Dallan LAP, Forrest JK, Reardon MJ, et al
    Redo-transcatheter aortic valve replacement with the supra-annular, self-expandable Evolut platform: Insights from the Transcatheter valve Therapy Registry.
    Catheter Cardiovasc Interv. 2021 Sep 17. doi: 10.1002/ccd.29941.
    PubMed     Abstract available


  95. BRIZIDO C, Madeira M, Brito J, Madeira S, et al
    Surgical versus transcatheter aortic valve replacement in low-risk patients: A long-term propensity score-matched analysis.
    Catheter Cardiovasc Interv. 2021 Sep 10. doi: 10.1002/ccd.29948.
    PubMed     Abstract available


  96. MEDRANDA GA, Rogers T, Ali SW, Zhang C, et al
    Prosthetic valve endocarditis after transcatheter aortic valve replacement in low-risk patients.
    Catheter Cardiovasc Interv. 2021 Sep 10. doi: 10.1002/ccd.29943.
    PubMed     Abstract available


  97. TANG GHL, Dangas GD
    Coronary access after valve-in-valve transcatheter aortic valve replacement: Time for a prospective study?
    Catheter Cardiovasc Interv. 2021;98:605-606.
    PubMed    


  98. ALKHOULI M, Jneid H
    Optimal management of acute decompensated aortic stenosis.
    Catheter Cardiovasc Interv. 2021;98:613-614.
    PubMed    


  99. COBB H, Spray B, Daily J, Dossey A, et al
    Cutting balloon angioplasty on branch pulmonary artery stenosis in pediatric patients.
    Catheter Cardiovasc Interv. 2021;98:526-532.
    PubMed     Abstract available


  100. PETRI N, Lengenfelder B, Voelker W, Nordbeck P, et al
    Interventional closure of aortomitral perforation after TAVR: A case report.
    Catheter Cardiovasc Interv. 2021;98:E483-E485.
    PubMed     Abstract available


    August 2021
  101. CHANG CW, Wadia SK, Rastogi A, Stinis CT, et al
    A unique cause of coronary obstruction after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Aug 20. doi: 10.1002/ccd.29919.
    PubMed     Abstract available


  102. FERREIRA DE SALES I, Lodi-Junqueira L, Rafael Sant'Anna Athayde G, Eugenia Alcici M, et al
    Pulmonary artery pressure response to percutaneous mitral valvuloplasty: Associated factors and clinical implications.
    Catheter Cardiovasc Interv. 2021 Aug 20. doi: 10.1002/ccd.29926.
    PubMed     Abstract available


  103. AMGAI B, Patel N, Chakraborty S, Bandyopadhyay D, et al
    30-day readmission following urgent and elective transcatheter aortic valve replacement: A Nationwide Readmission Database analysis.
    Catheter Cardiovasc Interv. 2021 Aug 19. doi: 10.1002/ccd.29918.
    PubMed     Abstract available


  104. BRUGGER N, Kassar M, Siontis GCM, Widmer S, et al
    Integrative echocardiographic assessment of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair.
    Catheter Cardiovasc Interv. 2021 Aug 18. doi: 10.1002/ccd.29916.
    PubMed     Abstract available


  105. CHOI CH, Cao K, Malaver D, Kincaid EH, et al
    Redo-aortic valve replacement in prior stentless prosthetic aortic valves: Transcatheter versus surgical approach.
    Catheter Cardiovasc Interv. 2021 Aug 17. doi: 10.1002/ccd.29921.
    PubMed     Abstract available


  106. GARCIA-GOMEZ M, Delgado-Arana JR, Halim J, De Marco F, et al
    Next-generation balloon-expandable Myval transcatheter heart valve in low-risk aortic stenosis patients.
    Catheter Cardiovasc Interv. 2021 Aug 14. doi: 10.1002/ccd.29923.
    PubMed     Abstract available


  107. FUKUTOMI M, Hokken T, Wong I, Bieliauskas G, et al
    Prophylactic permanent pacemaker strategy in patients with right bundle branch block undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Aug 14. doi: 10.1002/ccd.29914.
    PubMed     Abstract available


  108. BRIGUORI C, Scarpelli M
    The "locking and dragging" technique a facilitated crossover balloon occlusion technique for complex iliofemoral anatomy in transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Aug 14. doi: 10.1002/ccd.29915.
    PubMed     Abstract available


  109. MINHA S, Yarkoni Y, Segev A, Finkelstein A, et al
    Comparison of permanent pacemaker implantation rate after first and second generation of transcatheter aortic valve implantation-A retrospective cohort study.
    Catheter Cardiovasc Interv. 2021 Aug 4. doi: 10.1002/ccd.29891.
    PubMed     Abstract available


  110. NONA P, Mahmood S, Lemor A, Qintar M, et al
    Incidence of acquired ventricular septal defect after transcatheter aortic valve replacement: A large single center experience.
    Catheter Cardiovasc Interv. 2021 Aug 3. doi: 10.1002/ccd.29897.
    PubMed     Abstract available


  111. GUDDETI RR, Pajjuru VS, Walters RW, Garcia SA, et al
    Impact of gender on in-hospital mortality and 90-day readmissions in patients undergoing transcatheter edge-to-edge mitral valve repair: Analysis from the National Readmission Database.
    Catheter Cardiovasc Interv. 2021 Aug 3. doi: 10.1002/ccd.29887.
    PubMed     Abstract available


  112. TARANTINI G, Cardaioli F
    Transcatheter aortic valve replacement and chronic kidney disease: Close friends or sworn enemies?
    Catheter Cardiovasc Interv. 2021;98:328-329.
    PubMed    


  113. FRANZONE A, Esposito G
    Transcatheter aortic valve thrombosis: The more we see the more we know.
    Catheter Cardiovasc Interv. 2021;98:363-364.
    PubMed    


  114. BELARDI JA, Lamelas PM
    New TAVR item added to cart for large scale clinical testing.
    Catheter Cardiovasc Interv. 2021;98:380-381.
    PubMed    


  115. RIMMAUDO F, Angelini G, Condello I
    Thrombocytopenia after TAVI in patients with low body mass index.
    Catheter Cardiovasc Interv. 2021;98:E329-E331.
    PubMed    


  116. KREUTZER J, Armstrong AK, Rome JJ, Zellers TM, et al
    Comparison of the investigational device exemption and post-approval trials of the Melody transcatheter pulmonary valve.
    Catheter Cardiovasc Interv. 2021;98:E262-E274.
    PubMed     Abstract available


  117. KARIMIANPOUR A, Heizer J, Leaphart D, Rier JD, et al
    Predicting complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy using a risk stratification model and clinical tool.
    Catheter Cardiovasc Interv. 2021;98:393-400.
    PubMed     Abstract available


  118. QURESHI WT, Parker M, Walker J, Kakouros N, et al
    Equipment entrapment during redo-TAVR with successful BASILICA procedure.
    Catheter Cardiovasc Interv. 2021;98:E320-E323.
    PubMed     Abstract available


    July 2021
  119. VAN MIEGHEM NM, Windecker S, Manoharan G, Bosmans J, et al
    Final 3-year clinical outcomes following transcatheter aortic valve implantation with a supra-annular self-expanding repositionable valve in a real-world setting: Results from the multicenter FORWARD study.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29889.
    PubMed     Abstract available


  120. STAUDACHER DL, Braxmeier K, Stachon P, Hilgendorf I, et al
    Ventral calcification in the common femoral artery: A risk factor for major transcatheter aortic valve intervention access site complications.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29885.
    PubMed     Abstract available


  121. URENA M, Lemann T, Chong-Nguyen C, Brochet E, et al
    Causes and predictors of mortality after transcatheter mitral valve implantation in patients with severe mitral annulus calcification.
    Catheter Cardiovasc Interv. 2021 Jul 15. doi: 10.1002/ccd.29874.
    PubMed     Abstract available


  122. GOITIA J, Phan DQ, Lee MS, Moore N, et al
    The role of neighborhood disadvantage in predicting mortality in patients after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jul 14. doi: 10.1002/ccd.29872.
    PubMed     Abstract available


  123. OGUZ D, Padang R, Pislaru SV, Nkomo VT, et al
    Clinical predictors and impact of postoperative mean gradient on outcome after transcatheter edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2021 Jul 10. doi: 10.1002/ccd.29867.
    PubMed     Abstract available


  124. ISOGAI T, Saad AM, Ahuja KR, Shekhar S, et al
    Incidence, treatment, and outcomes of acute myocardial infarction following transcatheter or surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jul 8. doi: 10.1002/ccd.29860.
    PubMed     Abstract available


  125. HERMILLER JB JR, Gunnarsson CL, Ryan MP, Moore KA, et al
    The need for future coronary access following surgical or transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jul 6. doi: 10.1002/ccd.29841.
    PubMed     Abstract available


  126. POSTALIAN A, Krajcer Z
    Transcatheter aortic valve replacement has not helped bridge the racial disparity gap.
    Catheter Cardiovasc Interv. 2021;98:157-158.
    PubMed    


  127. ELGENDY IY, Jneid H
    Worsening renal function after transcatheter aortic valve replacement: Infrequent but deleterious.
    Catheter Cardiovasc Interv. 2021;98:195-196.
    PubMed    


  128. CILINGIROGLU M, Okutucu S
    TAVR in patients with end stage liver and renal disease: Lifesaving and increasing transplant eligibility.
    Catheter Cardiovasc Interv. 2021;98:168-169.
    PubMed    


    June 2021
  129. ISOGAI T, Saad AM, Michihata N, Ahuja KR, et al
    Association of hospital procedural volume with incidence and outcomes of surgical bailout in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jun 29. doi: 10.1002/ccd.29847.
    PubMed     Abstract available


  130. ROTTLANDER D, Godde M, Degen H, Ogutcu A, et al
    Procedural planning of CS-based indirect mitral annuloplasty using CT-angiography.
    Catheter Cardiovasc Interv. 2021 Jun 25. doi: 10.1002/ccd.29824.
    PubMed     Abstract available


  131. KHAN MZ, Zahid S, Khan MU, Kichloo A, et al
    Use and outcomes of cerebral embolic protection for transcatheter aortic valve replacement: A US nationwide study.
    Catheter Cardiovasc Interv. 2021 Jun 19. doi: 10.1002/ccd.29842.
    PubMed     Abstract available


  132. AL-KASSOU B, Shamekhi J, Weber M, Germeroth J, et al
    Frailty, malnutrition, and the endocrine system impact outcome in patients undergoing aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jun 18. doi: 10.1002/ccd.29821.
    PubMed     Abstract available


  133. FISCHER-RASOKAT U, Renker M, Liebetrau C, Weferling M, et al
    Prognostic impact of echocardiographic mean transvalvular gradients in patients with aortic stenosis and low flow undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Jun 17. doi: 10.1002/ccd.29840.
    PubMed     Abstract available


  134. NICOLAS J, Guedeney P, Claessen BE, Mehilli J, et al
    Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry.
    Catheter Cardiovasc Interv. 2021 Jun 12. doi: 10.1002/ccd.29807.
    PubMed     Abstract available


  135. SALEEM S, Ullah W, Syed MA, Megaly M, et al
    Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve.
    Catheter Cardiovasc Interv. 2021 Jun 10. doi: 10.1002/ccd.29789.
    PubMed     Abstract available


  136. ENG MH, Kargoli F, Wang DD, Frisoli TM, et al
    Short- and mid-term outcomes in percutaneous mitral valve replacement using balloon expandable valves.
    Catheter Cardiovasc Interv. 2021 Jun 9. doi: 10.1002/ccd.29783.
    PubMed     Abstract available


  137. MAIER O, Piayda K, Afzal S, Polzin A, et al
    Computed tomography derived predictors of permanent pacemaker implantation after transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2021 Jun 2. doi: 10.1002/ccd.29805.
    PubMed     Abstract available


  138. SCHOECHLIN S, Schulz U, Ruile P, Hein M, et al
    Impact of high-sensitivity cardiac troponin T on survival and rehospitalization after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jun 2. doi: 10.1002/ccd.29781.
    PubMed     Abstract available


  139. NICOLAS J, Mehran R
    Access routes in transcatheter aortic valve replacement: All roads lead to Rome but only one is paved.
    Catheter Cardiovasc Interv. 2021;97:1470-1471.
    PubMed    


  140. TARANTINI G, Nai Fovino L
    Treatment of degenerated surgical aortic valve: The importance of having a "lifetime strategy" in younger patients with severe aortic disease.
    Catheter Cardiovasc Interv. 2021;97:1489-1491.
    PubMed    


  141. REILLY JP, Parikh PB
    Transcarotid transcatheter aortic valve replacement: The best alternative?
    Catheter Cardiovasc Interv. 2021;97:1460-1461.
    PubMed    


  142. VUKADINOVIKJ A, Baumgartner E, Bohmann K, Harter D, et al
    Transcatheter valve-in-valve implantation versus surgical redo aortic root replacement in patients with degenerated freestyle aortic bioprosthesis.
    Catheter Cardiovasc Interv. 2021;97:1472-1478.
    PubMed     Abstract available


  143. KADADO AJ, Islam A
    Iatrogenic atrial septal defect following the MitraClip procedure: A state-of-the-art review.
    Catheter Cardiovasc Interv. 2021;97:E1043-E1052.
    PubMed     Abstract available


  144. IMAMURA T, Narang N
    Improving clinical outcomes following MitraClip.
    Catheter Cardiovasc Interv. 2021;97:E1053.
    PubMed    


    May 2021
  145. EL-SABAWI B, Guerrero ME, Eleid MF, Nkomo VT, et al
    Hemolysis after transcatheter mitral valve replacement in degenerated bioprostheses, annuloplasty rings, and mitral annular calcification: Incidence, patient characteristics, and clinical outcomes.
    Catheter Cardiovasc Interv. 2021 May 31. doi: 10.1002/ccd.29779.
    PubMed     Abstract available


  146. MEDRANDA GA, Case BC, Zhang C, Rappaport H, et al
    Propensity-matched comparison of large-bore access closure in transcatheter aortic valve replacement using MANTA versus Perclose: A real-world experience.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29786.
    PubMed     Abstract available


  147. ROMEO FJ, Chiabrando JG, Seropian IM, Raleigh JV, et al
    Sarcopenia index as a predictor of clinical outcomes in older patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 May 27. doi: 10.1002/ccd.29799.
    PubMed     Abstract available


  148. LIM DS, Smith RL, Zahr F, Dhoble A, et al
    Early outcomes from the CLASP IID trial roll-in cohort for prohibitive risk patients with degenerative mitral regurgitation.
    Catheter Cardiovasc Interv. 2021 May 18. doi: 10.1002/ccd.29749.
    PubMed     Abstract available


  149. MCGRATH DP, Kawabori M, Wessler B, Chen FY, et al
    A meta-analysis of transcarotid versus transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 May 12. doi: 10.1002/ccd.29768.
    PubMed     Abstract available


  150. LIU X, Pu Z, Lim DS, Wang J, et al
    Transcatheter mitral valve repair in a high-surgical risk patient with severe degenerative mitral regurgitation using the novel DragonFly Transcatheter Repair device-First in man implantation in China.
    Catheter Cardiovasc Interv. 2021 May 4. doi: 10.1002/ccd.29687.
    PubMed     Abstract available


  151. ARANZULLA TC, Musumeci G
    Clipping mitral valve or atrial fibrillation? Two is better than one!
    Catheter Cardiovasc Interv. 2021;97:1257-1258.
    PubMed    


  152. TARANTINI G, Fraccaro C
    Tailwind of transcatheter mitral valve repair pushes forward the treatment of acute mitral regurgitation after myocardial infarction.
    Catheter Cardiovasc Interv. 2021;97:1268-1269.
    PubMed    


  153. CILINGIROGLU M, Marmagkiolis K
    Should the mean left atrial pressure be the ultimate goal after TMVR?
    Catheter Cardiovasc Interv. 2021;97:1250-1251.
    PubMed    


  154. PIERRE K, Adedinsewo DA, Al-Hijji M, Miranda WR, et al
    30-day patient reported outcomes can be predicted by change in left atrial pressure and not change in transmitral gradient following MitraClip.
    Catheter Cardiovasc Interv. 2021;97:1244-1249.
    PubMed     Abstract available


  155. KROON HG, Tonino PAL, Savontaus M, Amoroso G, et al
    Dedicated plug based closure for large bore access -The MARVEL prospective registry.
    Catheter Cardiovasc Interv. 2021;97:1270-1278.
    PubMed     Abstract available


    April 2021
  156. MORENO R, Baz JA, Moreu J, Berenguer A, et al
    Transcatheter aortic valve implantation for degenerated aortic valves: Experience with a new supra-annular device. The Spanish Allegra valve-in-valve (SAVIV) registry.
    Catheter Cardiovasc Interv. 2021 Apr 23. doi: 10.1002/ccd.29742.
    PubMed     Abstract available


  157. HERRMANN HC, Laskey WK
    Pressure loss recovery in aortic valve stenosis: Contemporary relevance.
    Catheter Cardiovasc Interv. 2021 Apr 22. doi: 10.1002/ccd.29729.
    PubMed     Abstract available


  158. CHANDRA P, Jose J, Mattummal S, Mahajan AU, et al
    Clinical evaluation of the Hydra self-expanding transcatheter aortic valve: 6 month results from the GENESIS trial.
    Catheter Cardiovasc Interv. 2021 Apr 20. doi: 10.1002/ccd.29733.
    PubMed     Abstract available


  159. OKUNO T, Heg D, Lanz J, Praz F, et al
    Heart valve sizing and clinical outcomes in patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29700.
    PubMed     Abstract available


  160. PANCHAL HB, Stone GW, Saxena A, Bursac Z, et al
    In-hospital outcomes after transcatheter edge-to-edge mitral valve repair in patients with chronic kidney disease: An analysis from the 2010-2016 National inpatient sample.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29712.
    PubMed     Abstract available


  161. MARTINEZ-GOMEZ E, McInerney A, Tirado-Conte G, de Agustin JA, et al
    Percutaneous mitral valve repair with MitraClip device in hemodynamically unstable patients: A systematic review.
    Catheter Cardiovasc Interv. 2021 Apr 15. doi: 10.1002/ccd.29703.
    PubMed     Abstract available


  162. COSTA G, D'Errigo P, Rosato S, Valvo R, et al
    Long-term outcomes of self-expanding versus balloon-expandable transcatheter aortic valves: Insights from the OBSERVANT study.
    Catheter Cardiovasc Interv. 2021 Apr 13. doi: 10.1002/ccd.29701.
    PubMed     Abstract available


  163. CHAKRABORTY S, Patel N, Bandyopadhyay D, Hajra A, et al
    Readmission following urgent transcatheter aortic valve implantation versus urgent balloon aortic valvuloplasty in patients with decompensated heart failure or cardiogenic shock.
    Catheter Cardiovasc Interv. 2021 Apr 5. doi: 10.1002/ccd.29690.
    PubMed     Abstract available


  164. FALASCONI G, Melillo F, Pannone L, Adamo M, et al
    Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study).
    Catheter Cardiovasc Interv. 2021 Apr 2. doi: 10.1002/ccd.29683.
    PubMed     Abstract available


  165. IRIART X, Guerin P, Jalal Z, Thambo JB, et al
    Edge to edge repair using a MitraClip for severe tricuspid valve regurgitation after a Mustard operation.
    Catheter Cardiovasc Interv. 2021 Apr 1. doi: 10.1002/ccd.29681.
    PubMed     Abstract available


  166. MUSUMECI G, Colopi M
    Coronary arterial disease in patients undergoing percutaneous edge-to-edge mitral valve repair: Handle with care.
    Catheter Cardiovasc Interv. 2021;97:925-926.
    PubMed    


  167. MAHTTA D, Jneid H
    Paravalvular leak after TAVR: remarkable improvement but not the time to shift focus.
    Catheter Cardiovasc Interv. 2021;97:903-904.
    PubMed    


  168. LANDES U, Kornowski R
    Same day discharge: How much less is more for TAVR patients?
    Catheter Cardiovasc Interv. 2021;97:948-949.
    PubMed    


  169. WELLE GA, El-Sabawi B, Thaden JJ, Greason KL, et al
    Effect of a fourth-generation transcatheter valve enhanced skirt on paravalvular leak.
    Catheter Cardiovasc Interv. 2021;97:895-902.
    PubMed     Abstract available


  170. MODINE T, Vincent F, Delhaye C, Van Belle E, et al
    A dedicated Y-shaped percutaneous ECMO cannula for femoral 2-in-1 vascular access during high-risk procedures.
    Catheter Cardiovasc Interv. 2021;97:959-961.
    PubMed     Abstract available


    March 2021
  171. WEICH H, van Veyeren LM
    A new over-the-wire percutaneous mitral balloon valvuloplasty technique.
    Catheter Cardiovasc Interv. 2021 Mar 31. doi: 10.1002/ccd.29664.
    PubMed     Abstract available


  172. BOEDER NF, Bayer M, Dorr O, Nef HM, et al
    Fusion imaging guided implantation of a Tricento transcatheter heart valve for severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2021 Mar 23. doi: 10.1002/ccd.29587.
    PubMed     Abstract available


  173. KABAHIZI A, Sheikh AS, Williams T, Tanseco K, et al
    Elective versus urgent in-hospital transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Mar 13. doi: 10.1002/ccd.29638.
    PubMed     Abstract available


  174. GRANOT Y, Merdler I, Finkelstein A, Arbel Y, et al
    Prognostic implication of right ventricular dysfunction and tricuspid regurgitation following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Mar 7. doi: 10.1002/ccd.29639.
    PubMed     Abstract available


  175. KITAMURA M, Fam NP, Braun D, Ruf T, et al
    12-Month outcomes of transcatheter tricuspid valve repair with the PASCAL system for severe tricuspid regurgitation.
    Catheter Cardiovasc Interv. 2021 Mar 4. doi: 10.1002/ccd.29583.
    PubMed     Abstract available


  176. AKHTAR YN, Walker WA, Shakur U, Smith G, et al
    Clinical outcomes of percutaneous debulking of tricuspid valve endocarditis in intravenous drug users.
    Catheter Cardiovasc Interv. 2021 Mar 1. doi: 10.1002/ccd.29584.
    PubMed     Abstract available


  177. POSTALIAN A, Krajcer Z
    The best option to treat transplant recipients with severe aortic stenosis.
    Catheter Cardiovasc Interv. 2021;97:699-700.
    PubMed    


  178. KONERU S, Jneid H
    Rescue valve-in-valve TAVI: Buy one get one free!
    Catheter Cardiovasc Interv. 2021;97:712-713.
    PubMed    


  179. ENG MH, Fang HK
    Transcarotid: A sign from above?
    Catheter Cardiovasc Interv. 2021;97:734-735.
    PubMed    


  180. SINGH GD, Rogers JH, Chen S, Yap J, et al
    Adjunctive use of fluoroscopy during MitraClip implantation reduces procedural complexity: The parallax technique.
    Catheter Cardiovasc Interv. 2021;97:745-754.
    PubMed     Abstract available


  181. KOOISTRA NH, Intan-Goey VMP, Ziviello F, Leenders GE, et al
    Comparison of the Sapien 3 versus the ACURATE neo valve system: A propensity score analysis.
    Catheter Cardiovasc Interv. 2021;97:E597-E606.
    PubMed     Abstract available


  182. HIBINO M, Tabata M, Ito J, Shibayama K, et al
    Midterm outcomes after the rescue THV-in-THV procedure: Insights from the multicenter prospective OCEAN-TAVI registry.
    Catheter Cardiovasc Interv. 2021;97:701-711.
    PubMed     Abstract available


    February 2021
  183. MOUYEN T, Manigold T, Collet JP, Durand E, et al
    Transcatheter aortic valve thrombosis: Data from a French multicenter cohort analysis.
    Catheter Cardiovasc Interv. 2021 Feb 21. doi: 10.1002/ccd.29555.
    PubMed     Abstract available


  184. ESTEVEZ-LOUREIRO R, Shuvy M, Taramasso M, Benito-Gonzalez T, et al
    Use of MitraClip for mitral valve repair in patients with acute mitral regurgitation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Registry).
    Catheter Cardiovasc Interv. 2021 Feb 18. doi: 10.1002/ccd.29552.
    PubMed     Abstract available


  185. SHARMA RK, Tuttle MK, Poulin MF, Laham RJ, et al
    CoreValve bioprosthesis dysfunction treated with a Sapien 3 valve-in-valve transcatheter aortic valve replacement and BASILICA technique.
    Catheter Cardiovasc Interv. 2021 Feb 17. doi: 10.1002/ccd.29544.
    PubMed     Abstract available


  186. CAUGHRON H, Parikh D, Allison Z, Deuse T, et al
    Outcomes of transcatheter aortic valve replacement in end stage liver and renal disease.
    Catheter Cardiovasc Interv. 2021 Feb 17. doi: 10.1002/ccd.29559.
    PubMed     Abstract available


  187. KUMAR A, Sammour Y, Reginauld S, Sato K, et al
    Adverse clinical outcomes in patients undergoing both PCI and TAVR: Analysis from a pooled multi-center registry.
    Catheter Cardiovasc Interv. 2021;97:529-539.
    PubMed     Abstract available


  188. ARSLAN F, Akdim F, Ten Berg JM
    Reverse remodeling after percutaneous transluminal septal myocardial ablation in severe but asymptomatic LVOT obstruction (RASTA) study: Rationale and design of transcatheter septal reduction in asymptomatic patients with severe hypertrophic obstructi
    Catheter Cardiovasc Interv. 2021;97:488-492.
    PubMed     Abstract available


  189. SIMPSON TF, Tuohy CV, Rajotte K, Golwala H, et al
    Bioprosthetic valve oversizing is associated with increased risk of valve thrombosis following TAVR.
    Catheter Cardiovasc Interv. 2021;97:E411-E417.
    PubMed     Abstract available


  190. KHOKHAR AA, Laricchia A, Ponticelli F, Kim WK, et al
    Computed tomography analysis of coronary ostia location following valve-in-valve transcatheter aortic valve replacement with the ACURATE neo valve: Implications for coronary access.
    Catheter Cardiovasc Interv. 2021 Feb 14. doi: 10.1002/ccd.29503.
    PubMed     Abstract available


  191. THANDRA A, Abusnina W, Jhand A, Shaikh K, et al
    Valve-in-valve transcatheter aortic valve replacement versus redo surgical valve replacement for degenerated bioprosthetic aortic valve: An updated meta-analysis comparing midterm outcomes.
    Catheter Cardiovasc Interv. 2021 Feb 13. doi: 10.1002/ccd.29541.
    PubMed     Abstract available


  192. ADLAM D, Chan N, Baron J, Kovac J, et al
    Aortic stenosis in the time of COVID-19: Development and outcomes of a rapid turnaround TAVI service.
    Catheter Cardiovasc Interv. 2021 Feb 10. doi: 10.1002/ccd.29550.
    PubMed     Abstract available


  193. HALE SM, Jessen M, Banerjee S, Kumbhani DJ, et al
    Successful transcatheter treatment for very late migration of a transcatheter aortic valve into the left ventricular outflow tract.
    Catheter Cardiovasc Interv. 2021 Feb 10. doi: 10.1002/ccd.29547.
    PubMed     Abstract available


  194. KIR D, Shapero K, Chatterjee S, Grimshaw A, et al
    Effect of institutional transcatheter aortic valve replacement volume on mortality: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021 Feb 10. doi: 10.1002/ccd.29502.
    PubMed     Abstract available


  195. BANGALORE S, Alviar CL, Vlahakis S, Keller N, et al
    Tricuspid valve vegetation debulking using the AngioVac system.
    Catheter Cardiovasc Interv. 2021 Feb 10. doi: 10.1002/ccd.29519.
    PubMed     Abstract available


  196. SA MPBO, Simonato M, Van den Eynde J, Cavalcanti LRP, et al
    Balloon versus self-expandable transcatheter aortic valve implantation for bicuspid aortic valve stenosis: A meta-analysis of observational studies.
    Catheter Cardiovasc Interv. 2021 Feb 8. doi: 10.1002/ccd.29538.
    PubMed     Abstract available


  197. YONG MS, Camuglia AC, Cox SV, Cole CM, et al
    Plaster pipes and crystalized graphite: Open transventricular transcatheter aortic valve replacement for failed mechanical aortic valve prostheses in the porcelain aorta.
    Catheter Cardiovasc Interv. 2021 Feb 6. doi: 10.1002/ccd.29465.
    PubMed     Abstract available


  198. AL-HIJJI MA, ElHajj S, El Sabbagh A, Alkhouli MA, et al
    Temporal outcomes of transcatheter mitral valve replacement in native mitral valve disease with annular calcification.
    Catheter Cardiovasc Interv. 2021 Feb 4. doi: 10.1002/ccd.29515.
    PubMed     Abstract available


  199. VAN WIECHEN MP, Kroon H, Hokken TW, Ooms JF, et al
    Vascular complications with a plug-based vascular closure device after transcatheter aortic valve replacement: Predictors and bail-outs.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29506.
    PubMed     Abstract available


  200. SEJR-HANSEN M, Christiansen EH, Ahmad Y, Vendrik J, et al
    Performance of quantitative flow ratio in patients with aortic stenosis undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29518.
    PubMed     Abstract available


  201. KHAN MZ, Zahid S, Khan MU, Kichloo A, et al
    In-hospital outcomes of transcatheter mitral valve repair in patients with and without end stage renal disease: A national propensity match study.
    Catheter Cardiovasc Interv. 2021 Feb 1. doi: 10.1002/ccd.29517.
    PubMed     Abstract available


  202. ERINNE I, Sethi A, Johannesen J, Kassotis J, et al
    Racial disparities in the treatment of aortic stenosis: Has transcatheter aortic valve replacement bridged the gap?
    Catheter Cardiovasc Interv. 2021 Feb 1. doi: 10.1002/ccd.29487.
    PubMed     Abstract available


  203. POSTALIAN A, Krajcer Z
    How often is urgent surgery required to address transcatheter mitral valve repair complications?
    Catheter Cardiovasc Interv. 2021;97:342-343.
    PubMed    


  204. ENG MH, Verma DR
    Mitral valve-in-ring: Simply complicated.
    Catheter Cardiovasc Interv. 2021;97:359-360.
    PubMed    


  205. MUSUMECI G, Annibali G
    Access site vascular complications in TAVR: Is this the right time?
    Catheter Cardiovasc Interv. 2021;97:333-334.
    PubMed    


  206. RUGE H, Burri M, Erlebach M, Lange R, et al
    Access site related vascular complications with third generation transcatheter heart valve systems.
    Catheter Cardiovasc Interv. 2021;97:325-332.
    PubMed     Abstract available


  207. KARAHALIOS B, Breinholt JP, Little SH, Huie Lin C, et al
    Intentional bioprosthetic tricuspid valve fracture to facilitate transcatheter valve-in-valve deployment.
    Catheter Cardiovasc Interv. 2021;97:361-364.
    PubMed     Abstract available


    January 2021
  208. SIMARD T, Alqahtani F, Hibbert B, Mamas MA, et al
    Sex-specific in-hospital outcomes of transcatheter aortic valve replacement with third generation transcatheter heart valves.
    Catheter Cardiovasc Interv. 2021 Jan 31. doi: 10.1002/ccd.29499.
    PubMed     Abstract available


  209. SAMMOUR Y, Kerrigan J, Banerjee K, Gajulapalli RD, et al
    Comparing outcomes of general anesthesia and monitored anesthesia care during transcatheter aortic valve replacement: The Cleveland Clinic Foundation experience.
    Catheter Cardiovasc Interv. 2021 Jan 29. doi: 10.1002/ccd.29496.
    PubMed     Abstract available


  210. MYAT A, Mouy F, Buckner L, Cockburn J, et al
    Survival relative to pacemaker status after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2021 Jan 27. doi: 10.1002/ccd.29498.
    PubMed     Abstract available


  211. CARRETERO BELLON JM, Morr IC, Merchan EF, Prada FH, et al
    Expanding percutaneous treatment of mitral valve diseases: Transcatheter closure of mitral valve leaflet perforation.
    Catheter Cardiovasc Interv. 2021 Jan 27. doi: 10.1002/ccd.29467.
    PubMed     Abstract available


  212. QINTAR M, Wang DD, O'Neill WW, O'Neill B, et al
    Non-coaptation of an implanted caval valve leaflets for severe tricuspid regurgitation: Rethinking the concept of "Eustachian ridge?"
    Catheter Cardiovasc Interv. 2021 Jan 25. doi: 10.1002/ccd.29461.
    PubMed     Abstract available


  213. ITO N, Zen K, Kuwabara K, Matoba S, et al
    Recapture failure in transcatheter aortic valve replacement with CoreValve Evolut R.
    Catheter Cardiovasc Interv. 2021 Jan 22. doi: 10.1002/ccd.29580.
    PubMed     Abstract available


  214. SCHOTT JP, Dixon SR, Goldstein JA
    Disparate impact of severe aortic and mitral regurgitation on left ventricular dilation.
    Catheter Cardiovasc Interv. 2021 Jan 20. doi: 10.1002/ccd.29455.
    PubMed     Abstract available


  215. MEIJERINK F, Koch KT, de Winter RJ, Robbers-Visser D, et al
    Tricuspid regurgitation after transcatheter mitral valve repair: Clinical course and impact on outcome.
    Catheter Cardiovasc Interv. 2021 Jan 18. doi: 10.1002/ccd.29464.
    PubMed     Abstract available


  216. NIJENHUIS VJ, Meyer A, Brouwer J, Mahmoodi BK, et al
    The effect of transcatheter aortic valve implantation approaches on mortality.
    Catheter Cardiovasc Interv. 2021 Jan 14. doi: 10.1002/ccd.29456.
    PubMed     Abstract available


  217. ROHM CL, Farhat S, Al-Hijji M, Goel K, et al
    Endovascular snare technique to facilitate delivery of self-expanding valve during transcatheter aortic valve-in-valve replacement in angulated aortas: A case series.
    Catheter Cardiovasc Interv. 2021 Jan 11. doi: 10.1002/ccd.29459.
    PubMed     Abstract available


  218. ELBADAWI A, Ugwu J, Elgendy IY, Megaly M, et al
    Outcomes of transcatheter versus surgical aortic valve replacement among solid organ transplant recipients.
    Catheter Cardiovasc Interv. 2021 Jan 5. doi: 10.1002/ccd.29426.
    PubMed     Abstract available


  219. MARMAGKIOLIS K, Cilingiroglu M
    TAVR in cancer; healing the sickest of the sick.
    Catheter Cardiovasc Interv. 2021;97:165-166.
    PubMed    


  220. SAKAI K, Ohno Y, Miyamoto J, Horinouchi H, et al
    Optimizing self-expandable transcatheter heart valve sizing in patients with small sinus of Valsalva.
    Catheter Cardiovasc Interv. 2021;97:E168-E171.
    PubMed     Abstract available


  221. VOGT JC, Michelena HI, Nishimura RA, Nkomo VT, et al
    Diastolic blood pressure predicts outcomes after aortic paravalvular leak closure.
    Catheter Cardiovasc Interv. 2021;97:E79-E87.
    PubMed     Abstract available


    December 2020
  222. PERDONCIN E, Greenbaum AB, Grubb KJ, Babaliaros VC, et al
    Safety of same-day discharge after uncomplicated, minimalist transcatheter aortic valve replacement in the COVID-19 era.
    Catheter Cardiovasc Interv. 2020 Dec 31. doi: 10.1002/ccd.29453.
    PubMed     Abstract available


  223. TANSECO KV, Alsanjari O, Cockburn J, Hildick-Smith D, et al
    Amplatzer device closure of femoral pseudoaneurysm after transcatheter aortic valve implantation: An alternative to surgical repair.
    Catheter Cardiovasc Interv. 2020 Dec 22. doi: 10.1002/ccd.29424.
    PubMed     Abstract available


  224. PHAN DQ, Lee MS, Aharonian V, Mansukhani P, et al
    Association between mid-term worsening renal function and mortality after transcatheter aortic valve replacement in patients with chronic kidney disease.
    Catheter Cardiovasc Interv. 2020 Dec 17. doi: 10.1002/ccd.29429.
    PubMed     Abstract available


  225. LECLERCQ F, Choteau R, Cayla G, Chamard C, et al
    Transcarotid versus transfemoral access in patients undergoing transcatheter aortic valve replacement with complex aortofemoral anatomy.
    Catheter Cardiovasc Interv. 2020 Dec 16. doi: 10.1002/ccd.29438.
    PubMed     Abstract available


  226. ANCONA MB, Beneduce A, Romano V, Buzzatti N, et al
    Self-expanding transcatheter aortic valve infolding: Current evidence, diagnosis, and management.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29432.
    PubMed     Abstract available


  227. AMAT-SANTOS IJ, Santos-Martinez S, Conradi L, Taramasso M, et al
    Transaxillary transcatheter ACURATE neo aortic valve implantation - The TRANSAX multicenter study.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29423.
    PubMed     Abstract available


  228. KRAJCER Z, Costello B
    Effect of concomitant aortic regurgitation on early hypoattenuated leaflet thickening after transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis.
    Catheter Cardiovasc Interv. 2020;96:1498-1499.
    PubMed     Abstract available


    November 2020
  229. GIFFT K, Omran J, Ghrair F, Allaham H, et al
    Impact of preexisting coronary arterial disease in patients undergoing percutaneous mitral valve repair (MitraClip).
    Catheter Cardiovasc Interv. 2020 Nov 28. doi: 10.1002/ccd.29404.
    PubMed     Abstract available


  230. BAEKKE PS, Jorgensen TH, Sondergaard L
    Impact of early hospital discharge on clinical outcomes after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29403.
    PubMed     Abstract available


  231. SUGIURA A, Weber M, Tabata N, Goto T, et al
    Association of heart failure duration with clinical outcomes after transcatheter mitral valve repair for functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2020 Nov 19. doi: 10.1002/ccd.29390.
    PubMed     Abstract available


  232. RZUCIDLO J, Jaspan V, Paone D, Jilaihawi H, et al
    Long-term outcomes after transcatheter aortic valve replacement with minimal contrast in chronic kidney disease.
    Catheter Cardiovasc Interv. 2020 Nov 12. doi: 10.1002/ccd.29378.
    PubMed     Abstract available


  233. BENETOS G, Karmpalioti M, Drakopoulou M, Stathogiannis K, et al
    One-year clinical and echocardiographic outcomes of direct implantation of a self-expanding valve.
    Catheter Cardiovasc Interv. 2020 Nov 12. doi: 10.1002/ccd.29389.
    PubMed     Abstract available


  234. ALARFAJ M, Jain T, Krepp J
    Transcatheter mitral valve thrombosis: A case report and literature review.
    Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29374.
    PubMed     Abstract available


  235. SAYAH N, Simon F, Garceau P, Ducharme A, et al
    Initial clinical experience with VersaCross transseptal system for transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29365.
    PubMed     Abstract available


  236. ARORA S, Lahewala S, Zuzek Z, Thakkar S, et al
    Transcatheter aortic valve replacement in aortic regurgitation: The U.S. experience.
    Catheter Cardiovasc Interv. 2020 Nov 9. doi: 10.1002/ccd.29379.
    PubMed     Abstract available


  237. CASENGHI M, Gorla R, Popolo Rubbio A, De Marco F, et al
    One-year safety and efficacy profile of transcatheter aortic valve-in-valve implantation with the portico system.
    Catheter Cardiovasc Interv. 2020 Nov 6. doi: 10.1002/ccd.29353.
    PubMed     Abstract available


  238. CHIARITO M, Mehran R
    Transcatheter aortic valve replacement in patients with end-stage renal disease: Is "better than nothing" good enough?
    Catheter Cardiovasc Interv. 2020;96:1110-1112.
    PubMed    


  239. TARANTINI G, Fraccaro C
    Aortic valve replacement plus revascularization: The battle of surgical versus transcatheter approach still rages.
    Catheter Cardiovasc Interv. 2020;96:1126-1127.
    PubMed     Abstract available


  240. TARANTINI G, Masiero G
    Combined edge-to-edge tricuspid and mitral valve repair: Promising but still a long and bumpy road.
    Catheter Cardiovasc Interv. 2020;96:1331-1332.
    PubMed    


  241. POSTALIAN A, Krajcer Z
    Preventing tricuspid valve injury during transcatheter pulmonary valve replacement.
    Catheter Cardiovasc Interv. 2020;96:1294-1295.
    PubMed     Abstract available


    October 2020
  242. ABU KHADIJA H, Ayyad O, Haberman D, Gandelman G, et al
    Contemporary transcatheter aortic valve implantation related thrombocytopenia.
    Catheter Cardiovasc Interv. 2020 Oct 15. doi: 10.1002/ccd.29325.
    PubMed     Abstract available


  243. SIMONETTO F, Purita PAM, Malerba M, Barbierato M, et al
    Surgical redo versus transseptal or transapical transcatheter mitral valve-in-valve implantation for failed mitral valve bioprosthesis.
    Catheter Cardiovasc Interv. 2020 Oct 13. doi: 10.1002/ccd.29324.
    PubMed     Abstract available


  244. CHAWLA KK, Huang X, Hadro N, Islam AM, et al
    A novel technique to manage transcatheter aortic valve embolization.
    Catheter Cardiovasc Interv. 2020 Oct 10. doi: 10.1002/ccd.29279.
    PubMed     Abstract available


  245. SAMMOUR Y, Sato K, Kumar A, Gajulapalli RD, et al
    Impact of baseline conduction abnormalities on outcomes after transcatheter aortic valve replacement with SAPIEN-3.
    Catheter Cardiovasc Interv. 2020 Oct 3. doi: 10.1002/ccd.29309.
    PubMed     Abstract available


  246. NICOLAS J, Claessen BE, Cao D, Sartori S, et al
    Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN-TAVI registry.
    Catheter Cardiovasc Interv. 2020 Oct 1. doi: 10.1002/ccd.29276.
    PubMed     Abstract available


  247. KORBER MI, Friedrichs KP, Aydin F, Pfister R, et al
    Impact of cleft-like indentations on procedural outcome of percutaneous edge-to-edge mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Oct 1. doi: 10.1002/ccd.29286.
    PubMed     Abstract available


  248. MISUMIDA N, Guerrero M, Pislaru SV, Alkhouli M, et al
    Hemodynamic response to transseptal transcatheter mitral valve replacement in patients with severe mitral stenosis due to severe mitral annular calcification.
    Catheter Cardiovasc Interv. 2020 Oct 1. doi: 10.1002/ccd.29285.
    PubMed     Abstract available


  249. TARANTINI G, Nai Fovino L
    TAVR versus SAVR in patients with severe aortic stenosis and concomitant end stage liver disease: When less is more.
    Catheter Cardiovasc Interv. 2020;96:956-957.
    PubMed    


  250. OOI YS, Gray WA
    One in one equals two.
    Catheter Cardiovasc Interv. 2020;96:987-988.
    PubMed    


  251. ARANZULLA TC, Musumeci G
    Remove the obstacle and get into the flow!
    Catheter Cardiovasc Interv. 2020;96:979-980.
    PubMed    


    September 2020
  252. LUNARDI M, Franzese I, Faggian G, Ribichini FL, et al
    Hybrid treatment of aortic aneurism, type-A dissection, and aortic valve stenosis.
    Catheter Cardiovasc Interv. 2020 Sep 26. doi: 10.1002/ccd.29303.
    PubMed     Abstract available


  253. HOSHI T, Hiraya D, Sato A, Ieda M, et al
    Potential risk of perioperative thromboembolism in patients with antiphospholipid syndrome who undergo transcatheter aortic valve implantation: A case series.
    Catheter Cardiovasc Interv. 2020 Sep 25. doi: 10.1002/ccd.29300.
    PubMed     Abstract available


  254. MORITA Y, Endo A, Tanabe K
    Papillary muscle rupture after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Sep 23. doi: 10.1002/ccd.29252.
    PubMed     Abstract available


  255. MORIYAMA N, Lehtola H, Miyashita H, Piuhola J, et al
    Hemodynamic comparison of transcatheter aortic valve replacement with the SAPIEN 3 Ultra versus SAPIEN 3: The HomoSAPIEN registry.
    Catheter Cardiovasc Interv. 2020 Sep 23. doi: 10.1002/ccd.29281.
    PubMed     Abstract available


  256. HASE H, Yoshijima N, Yanagisawa R, Tanaka M, et al
    Transcatheter aortic valve replacement with Evolut R versus Sapien 3 in Japanese patients with a small aortic annulus: The OCEAN-TAVI registry.
    Catheter Cardiovasc Interv. 2020 Sep 14. doi: 10.1002/ccd.29259.
    PubMed     Abstract available


  257. IMAMURA T
    How to prevent thrombosis following transcatheter aortic valve replacement during durable left ventricular assist device supports.
    Catheter Cardiovasc Interv. 2020 Sep 14. doi: 10.1002/ccd.29268.
    PubMed    


  258. ALSHAWABKEH L, Mahmud E, Reeves R
    Percutaneous mitral valve repair in adults with congenital heart disease: Report of the first case-series.
    Catheter Cardiovasc Interv. 2020 Sep 8. doi: 10.1002/ccd.29238.
    PubMed     Abstract available


  259. KOMATSU I, Tang GHL, Leipsic J, Webb JG, et al
    Distribution of C-arm projections in native and bioprosthetic aortic valves cusps: Implication for BASILICA procedures.
    Catheter Cardiovasc Interv. 2020 Sep 7. doi: 10.1002/ccd.29224.
    PubMed     Abstract available


  260. SHARMA SP, Chaudhary R, Ghuneim A, Harder W, et al
    Carotid access for transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Sep 5. doi: 10.1002/ccd.29244.
    PubMed     Abstract available


  261. TARANTINI G, Baumgartner H, Frank D, Husser O, et al
    Four-year mortality in women and men after transfemoral transcatheter aortic valve implantation using the SAPIEN 3.
    Catheter Cardiovasc Interv. 2020 Sep 4. doi: 10.1002/ccd.29257.
    PubMed     Abstract available


  262. ANUWATWORN A, Bailey SR
    Predicting who benefits from mitral valve percutaneous repair: It's not just the valve.
    Catheter Cardiovasc Interv. 2020;96:698.
    PubMed    


  263. TARANTINI G, Masiero G
    Early readmission after mitral valve repair: God is in the details.
    Catheter Cardiovasc Interv. 2020;96:675-677.
    PubMed    


  264. ZAHR F, Cigaarroa JE
    Left atrial function, the cherrie on top in understanding clinical outcomes in functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2020;96:685-686.
    PubMed    


  265. PATEL ND, Nageotte S, Ing FF, Armstrong AK, et al
    Procedural, pregnancy, and short-term outcomes after fetal aortic valvuloplasty.
    Catheter Cardiovasc Interv. 2020;96:626-632.
    PubMed     Abstract available


  266. ZILBERSZAC R, Chandiramani R, Hengstenberg C, Sartori S, et al
    Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2020;96:E377-E386.
    PubMed     Abstract available


  267. PULS M, Huenlich M, Boekstegers P, Lubos E, et al
    Implantation of one versus two MitraClips in the German TRAMI registry: Is more always better?
    Catheter Cardiovasc Interv. 2020;96:E360-E368.
    PubMed     Abstract available


  268. JOHNSON DT, Fournier S, Kirkeeide RL, De Bruyne B, et al
    Phasic pressure measurements for coronary and valvular interventions using fluid-filled catheters: Errors, automated correction, and clinical implications.
    Catheter Cardiovasc Interv. 2020;96:E268-E277.
    PubMed     Abstract available


  269. PAL N, Jones D, Rice G, Sinhal A, et al
    Case report describing late balloon dilatation as a treatment for paravalvular leak with intuity elite rapid deployment valve.
    Catheter Cardiovasc Interv. 2020;96:E292-E294.
    PubMed     Abstract available


  270. SATHANANTHAN J, Hensey M, Fraser R, Landes U, et al
    Implications of hydrodynamic testing to guide sizing of self-expanding transcatheter heart valves for valve-in-valve procedures.
    Catheter Cardiovasc Interv. 2020;96:E332-E340.
    PubMed     Abstract available


    August 2020
  271. TONCHEV I, Heberman D, Peretz A, Medvedovsky AT, et al
    Acute kidney injury after MitraClip implantation in patients with severe mitral regurgitation.
    Catheter Cardiovasc Interv. 2020 Aug 31. doi: 10.1002/ccd.29250.
    PubMed     Abstract available


  272. SEKARAN N, Horne BD, Doty JR, Reid BB, et al
    Transcatheter mitral valve in ring, hazards of long anterior mitral leaflet and 3-dimensional rings.
    Catheter Cardiovasc Interv. 2020 Aug 31. doi: 10.1002/ccd.29232.
    PubMed     Abstract available


  273. PANOULAS VF, Chandrasekhar J, Busi G, Ruparelia N, et al
    Prevalence, predictors, and outcomes of patient prosthesis mismatch in women undergoing TAVI for severe aortic stenosis: Insights from the WIN-TAVI registry.
    Catheter Cardiovasc Interv. 2020 Aug 31. doi: 10.1002/ccd.29227.
    PubMed     Abstract available


  274. RUGGIERO R, Ponticelli F, Giannini F, Galvani M, et al
    Transcatheter aortic valve implantation for severe pure aortic regurgitation due to active aortitis.
    Catheter Cardiovasc Interv. 2020 Aug 31. doi: 10.1002/ccd.29249.
    PubMed     Abstract available


  275. ISOGAI T, Saad AM, Ahuja KR, Shekhar S, et al
    Short-term outcomes of transcatheter aortic valve replacement for pure native aortic regurgitation in the United States.
    Catheter Cardiovasc Interv. 2020 Aug 28. doi: 10.1002/ccd.29189.
    PubMed     Abstract available


  276. MAZZELLA AJ, Sanders M, Yang H, Li Q, et al
    Predicting need for pacemaker implantation early and late after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Aug 28. doi: 10.1002/ccd.29239.
    PubMed     Abstract available


  277. SAWALHA K, Al-Akchar M, Ibrahim A, Buhnerkempe M, et al
    Impact of chronic kidney disease on in-hospital outcomes and readmission rate after edge-to-edge transcatheter mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Aug 15. doi: 10.1002/ccd.29188.
    PubMed     Abstract available


  278. KASSIS N, Saad AM, Ahuja KR, Gad MM, et al
    Impact of thoracic aortic aneurysm on outcomes of transcatheter aortic valve replacement: A nationwide cohort analysis.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29195.
    PubMed     Abstract available


  279. DI CESARE A, Tonet E, Campo G, Tumscitz C, et al
    Snuffbox approach for balloon aortic valvuloplasty: A case series.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29196.
    PubMed     Abstract available


  280. MYAT A, Buckner L, Mouy F, Cockburn J, et al
    In-hospital stroke after transcatheter aortic valve implantation: A UK observational cohort analysis.
    Catheter Cardiovasc Interv. 2020 Aug 11. doi: 10.1002/ccd.29157.
    PubMed     Abstract available


  281. KHAN MU, Khan MZ, Khan SU, Kaluski E, et al
    Transcatheter mitral valve repair in patients with chronic liver disease: Insights from the national inpatient sample.
    Catheter Cardiovasc Interv. 2020 Aug 8. doi: 10.1002/ccd.29173.
    PubMed     Abstract available


  282. ISOGAI T, Saad AM, Shekhar S, Ahuja KR, et al
    Incidence and short-term outcomes of surgical bailout after transcatheter mitral valve repair with the MitraClip system.
    Catheter Cardiovasc Interv. 2020 Aug 8. doi: 10.1002/ccd.29153.
    PubMed     Abstract available


  283. BIANCARI F, Pykari J, Savontaus M, Laine M, et al
    Early and late pace-maker implantation after transcatheter and surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Aug 7. doi: 10.1002/ccd.29177.
    PubMed     Abstract available


  284. MAOZ-METZL D, McCarthy FH, Berson DG, Kunz GA, et al
    Transcatheter tricuspid valve replacement in dehisced flexible ring.
    Catheter Cardiovasc Interv. 2020 Aug 6. doi: 10.1002/ccd.29162.
    PubMed     Abstract available


  285. TARANTINI G, Fabris T
    Minimalist transfemoral transcatheter aortic valve replacement: Make it as simple as possible, but not simpler.
    Catheter Cardiovasc Interv. 2020;96:471-472.
    PubMed     Abstract available


  286. OLIVEIRA FA, Lemos PA
    TAVR patients count on their thrombocytes: Platelets count is accountable for the outcomes!
    Catheter Cardiovasc Interv. 2020;96:422-423.
    PubMed     Abstract available


  287. MUSUMECI G, Albani S
    US-guided vascular access and left ventricular rapid pacing in TAVR: Two simple points that may improve patients' outcomes.
    Catheter Cardiovasc Interv. 2020;96:440-441.
    PubMed     Abstract available


  288. TAN W, Calfon Press M, Lluri G, Aboulhosn J, et al
    Percutaneous edge-to-edge repair for common atrioventricular valve regurgitation in a patient with heterotaxy syndrome, single ventricle physiology, and unbalanced atrioventricular septal defect.
    Catheter Cardiovasc Interv. 2020;96:384-388.
    PubMed     Abstract available


  289. LAUCK SB, Sathananthan J, Park J, Achtem L, et al
    Post-procedure protocol to facilitate next-day discharge: Results of the multidisciplinary, multimodality but minimalist TAVR study.
    Catheter Cardiovasc Interv. 2020;96:450-458.
    PubMed     Abstract available


    July 2020
  290. ADDIS DR, Law M, von Mering G, Ahmed M, et al
    Codeployment of a percutaneous edge-to-edge mitral valve repair device and a ventriculoseptal defect occluder device to address complex mitral regurgitation with leaflet perforation.
    Catheter Cardiovasc Interv. 2020 Jul 31. doi: 10.1002/ccd.29147.
    PubMed     Abstract available


  291. YAMAMOTO M, Otsuka T, Shimura T, Yamaguchi R, et al
    Clinical risk model for predicting 1-year mortality after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 30. doi: 10.1002/ccd.29130.
    PubMed     Abstract available


  292. RAHEJA H, Ahuja KR, Nazir S, Saad AM, et al
    Association of baseline kidney disease with outcomes of transcatheter mitral valve repair by MitraClip.
    Catheter Cardiovasc Interv. 2020 Jul 23. doi: 10.1002/ccd.29129.
    PubMed     Abstract available


  293. SHEIKH MA, Deo SV, Riaz H, Raza S, et al
    Safety-net hospitals versus non-safety centers and clinical outcomes after trans-catheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 18. doi: 10.1002/ccd.29123.
    PubMed     Abstract available


  294. KOTRONIAS RA, Bray JH, Scarsini R, Rajasundaram S, et al
    Transcatheter aortic valve replacement and percutaneous coronary intervention versus surgical aortic valve replacement and coronary artery bypass grafting in patients with severe aortic stenosis and concomitant coronary artery disease: A systematic re
    Catheter Cardiovasc Interv. 2020 Jul 14. doi: 10.1002/ccd.29110.
    PubMed     Abstract available


  295. ADAMO M, Provini M, Fiorina C, Giannini C, et al
    Interaction between severe chronic kidney disease and acute kidney injury in predicting mortality after transcatheter aortic valve implantation: Insights from the Italian Clinical Service Project.
    Catheter Cardiovasc Interv. 2020 Jul 9. doi: 10.1002/ccd.28927.
    PubMed     Abstract available


  296. KHAN MZ, Khan MU, Kalra A, Krupica T, et al
    Transcatheter versus surgical aortic valve replacement in patients with end stage renal disease.
    Catheter Cardiovasc Interv. 2020 Jul 7. doi: 10.1002/ccd.29109.
    PubMed     Abstract available


  297. FRACCARO C, Campante Teles R, Tchetche D, Saia F, et al
    Transcatheter aortic valve implantation (TAVI) in cardiogenic shock: TAVI-shock registry results.
    Catheter Cardiovasc Interv. 2020 Jul 6. doi: 10.1002/ccd.29112.
    PubMed     Abstract available


  298. SATHANANTHAN J, Lauck S, Polderman J, Yu M, et al
    Ten year follow-up of high-risk patients treated during the early experience with transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jul 6. doi: 10.1002/ccd.29124.
    PubMed     Abstract available


  299. COSTA G, Ihlemann N, Sondergaard L, De Backer O, et al
    Spontaneous thrombosis of a transcatheter aortic valve replacement-induced aortic root pseudoaneurysm.
    Catheter Cardiovasc Interv. 2020 Jul 4. doi: 10.1002/ccd.29108.
    PubMed     Abstract available


  300. COSTA G, Bieliauskas G, Fukutomi M, Ihlemann N, et al
    Feasibility and safety of a fully percutaneous transcatheter aortic valve replacement program.
    Catheter Cardiovasc Interv. 2020 Jul 1. doi: 10.1002/ccd.29117.
    PubMed     Abstract available


  301. PARIKH PB, Reilly JP
    Women with chronic kidney disease undergoing transcatheter aortic valve replacement: Caveat emptor.
    Catheter Cardiovasc Interv. 2020;96:208-209.
    PubMed     Abstract available


  302. TARANTINI G, Giacoppo D
    Transcatheter versus surgical aortic valve replacement in the digital era: Meta-analysis based on the reconstruction of time-to-event individual patient data.
    Catheter Cardiovasc Interv. 2020;96:167-168.
    PubMed     Abstract available


  303. KORNOWSKI R
    Appraisal of urgent transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020;96:196-197.
    PubMed     Abstract available


  304. LARICCHIA A, Mangieri A, Colombo A, Giannini F, et al
    Perceval sutureless valve migration treated by valve-in-valve with a CoreValve Evolut Pro.
    Catheter Cardiovasc Interv. 2020;96:225-227.
    PubMed     Abstract available


  305. AKKAYA E, Sozener K, Rixe J, Tsiakou M, et al
    Venous access closure using a purse-string suture without heparin antagonism or additional compression after MitraClip implantation.
    Catheter Cardiovasc Interv. 2020;96:179-186.
    PubMed     Abstract available


  306. STRIPE BR, Singh GD, Smith T, Rogers JH, et al
    Retrieval of a MitraClip from the left atrium using a two-snare technique: Case report and review of the literature.
    Catheter Cardiovasc Interv. 2020;96:210-214.
    PubMed     Abstract available


    June 2020
  307. ROTTLANDER D, Ballof J, Godde M, Degen H, et al
    CT-Angiography to predict outcome after indirect mitral annuloplasty in patients with functional mitral regurgitation.
    Catheter Cardiovasc Interv. 2020 Jun 30. doi: 10.1002/ccd.29107.
    PubMed     Abstract available


  308. ROMEO FJ, Seropian IM, Chiabrando JG, Raleigh JV, et al
    Additive prognostic value of carbohydrate antigen-125 over frailty in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jun 28. doi: 10.1002/ccd.29067.
    PubMed     Abstract available


  309. BODE MF, Ahmed AA, Baron SJ, Labib SB, et al
    The use of MitraClip to prevent posttranscatheter aortic valve replacement left ventricular "suicide".
    Catheter Cardiovasc Interv. 2020 Jun 26. doi: 10.1002/ccd.29100.
    PubMed     Abstract available


  310. KOVACH CP, Bell S, Kataruka A, Reisman M, et al
    Outcomes of urgent/emergent transcatheter mitral valve repair (MitraClip): A single center experience.
    Catheter Cardiovasc Interv. 2020 Jun 26. doi: 10.1002/ccd.29084.
    PubMed     Abstract available


  311. MATSUDA Y, Nai Fovino L, Giacoppo D, Scotti A, et al
    Association between surgical risk and 30-day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Jun 25. doi: 10.1002/ccd.29105.
    PubMed     Abstract available


  312. GEYER M, Keller K, Born S, Bachmann K, et al
    Predictors of short- and long-term outcomes of patients undergoing transcatheter mitral valve edge-to-edge repair.
    Catheter Cardiovasc Interv. 2020 Jun 12. doi: 10.1002/ccd.29068.
    PubMed     Abstract available


  313. SATHANANTHAN J, Green P, Finn M, Wood DA, et al
    Prognostic implications of baseline 6-min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jun 10. doi: 10.1002/ccd.28981.
    PubMed     Abstract available


  314. TANG L, Sorajja P, Mooney M, Garberich R, et al
    Transcatheter aortic valve replacement in patients with severe comorbidities: A retrospective cohort study.
    Catheter Cardiovasc Interv. 2020 Jun 8. doi: 10.1002/ccd.29063.
    PubMed     Abstract available


  315. GE Z, Pan W, Zhou D, Li W, et al
    Effect of a novel transcatheter edge-to-edge repair device on the three-dimensional geometry of mitral valve in degenerative mitral regurgitation.
    Catheter Cardiovasc Interv. 2020 Jun 4. doi: 10.1002/ccd.29002.
    PubMed     Abstract available


  316. MURPHY AC, Koshy AN, Cameron W, Horrigan M, et al
    Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes.
    Catheter Cardiovasc Interv. 2020 Jun 4. doi: 10.1002/ccd.28969.
    PubMed     Abstract available


  317. TARANTINI G, Nai Fovino L
    Preexisting diastolic dysfunction in patients undergoing TAVR matters-But what about diastole the day after TAVR?
    Catheter Cardiovasc Interv. 2020;95:1338-1339.
    PubMed    


    May 2020
  318. SIQUEIRA DA, Simonato M, Ramos AA, Bignoto T, et al
    Mid- to long-term clinical and echocardiographic outcomes after transcatheter aortic valve replacement with a new-generation, self-expandable system.
    Catheter Cardiovasc Interv. 2020 May 23. doi: 10.1002/ccd.28999.
    PubMed     Abstract available


  319. LI SX, Patel NK, Flannery LD, Cigarroa RJ, et al
    Impact of bleeding after transcatheter aortic valve replacement in patients with chronic kidney disease.
    Catheter Cardiovasc Interv. 2020 May 22. doi: 10.1002/ccd.28989.
    PubMed     Abstract available


  320. OTERO D, Raza M, Kahlon T, Singh V, et al
    Transcatheter edge-to-edge mitral valve repair for annuloplasty ring dehiscence: The peri-ring approach.
    Catheter Cardiovasc Interv. 2020 May 21. doi: 10.1002/ccd.28952.
    PubMed     Abstract available


  321. SEPPELT PC, Mas-Peiro S, De Rosa R, Murray IM, et al
    Dynamics of cerebral oxygenation during rapid ventricular pacing and its impact on outcome in transfemoral transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 May 20. doi: 10.1002/ccd.28975.
    PubMed     Abstract available


  322. SAMMOUR Y, Kadri AN, Gajulapalli RD, Kaur M, et al
    Comparison of acute recoil after valve deployment and after post-dilation in patients undergoing transfemoral-transcatheter aortic valve replacement with SAPIEN-3 valve.
    Catheter Cardiovasc Interv. 2020 May 19. doi: 10.1002/ccd.28968.
    PubMed     Abstract available


  323. XIONG TY, Liao YB, Li YJ, Chen F, et al
    Effect of concomitant aortic regurgitation on early hypo-attenuated leaflet thickening after transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis.
    Catheter Cardiovasc Interv. 2020 May 13. doi: 10.1002/ccd.28903.
    PubMed     Abstract available


  324. GORLA R, De Marco F, Garatti A, Bianchi G, et al
    Impact of aortic angle on transcatheter aortic valve implantation outcome with Evolut-R, Portico, and Acurate-NEO.
    Catheter Cardiovasc Interv. 2020 May 13. doi: 10.1002/ccd.28957.
    PubMed     Abstract available


  325. GREENBAUM AB, Khan JM, Rogers T, Babaliaros VC, et al
    First-in-human transcatheter pledget-assisted suture tricuspid annuloplasty for severe tricuspid insufficiency.
    Catheter Cardiovasc Interv. 2020 May 8. doi: 10.1002/ccd.28955.
    PubMed     Abstract available


  326. OSMAN M, Khan MZ, Farjo PD, Khan MU, et al
    In-hospital outcomes of percutaneous mitral valve repair in patients with chronic obstructive pulmonary disease: insights from the national inpatient sample database.
    Catheter Cardiovasc Interv. 2020 May 6. doi: 10.1002/ccd.28913.
    PubMed     Abstract available


  327. VEULEMANS V, Maier O, Bosbach G, Polzin A, et al
    Novel insights on outcome in horizontal aorta with self-expandable new-generation transcatheter aortic valve replacement devices.
    Catheter Cardiovasc Interv. 2020 May 6. doi: 10.1002/ccd.28961.
    PubMed     Abstract available


  328. EL-SABAWI B, Guerrero ME, Eleid MF, Rihal CS, et al
    Acute fulminant hemolysis after transcatheter mitral valve replacement for mitral annular calcification.
    Catheter Cardiovasc Interv. 2020 May 6. doi: 10.1002/ccd.28944.
    PubMed     Abstract available


  329. LISKO J, Block PC
    The bicuspid aortic valve: Still a toothy problem.
    Catheter Cardiovasc Interv. 2020;95:1193-1194.
    PubMed     Abstract available


  330. SAIA F, Leone A
    Suprasternal access for transcatheter aortic valve implantation: All ways lead to Rome.
    Catheter Cardiovasc Interv. 2020;95:1184-1185.
    PubMed     Abstract available


  331. KIMMELSTIEL C, Rowin EJ
    Fixed, high-volume alcohol dose for septal ablation: High risk with no benefit.
    Catheter Cardiovasc Interv. 2020;95:1219-1220.
    PubMed     Abstract available


  332. KASHTANOV MG, Rzhannikova AD, Chernyshev SD, Kardapoltsev LV, et al
    Outcomes of hypertrophic obstructive cardiomyopathy patients undergoing alcohol septal ablation with a standard 3 mL dose of ethanol: Focus on long-term safety.
    Catheter Cardiovasc Interv. 2020;95:1212-1218.
    PubMed     Abstract available


    April 2020
  333. MISUMIDA N, Anderson JH, Greason KL, Rihal CS, et al
    Antegrade transseptal transcatheter aortic valve replacement: Back to the future?
    Catheter Cardiovasc Interv. 2020 Apr 30. doi: 10.1002/ccd.28934.
    PubMed     Abstract available


  334. PIAYDA K, Wimmer AC, Sievert H, Hellhammer K, et al
    Contemporary use of balloon aortic valvuloplasty and evaluation of its success in different hemodynamic entities of severe aortic valve stenosis.
    Catheter Cardiovasc Interv. 2020 Apr 27. doi: 10.1002/ccd.28950.
    PubMed     Abstract available


  335. NOGUCHI M, Tabata M, Obunai K, Shibayama K, et al
    Clinical outcomes of transcatheter aortic valve implantation (TAVI) in nonagenarians from the optimized catheter valvular intervention-TAVI registry.
    Catheter Cardiovasc Interv. 2020 Apr 25. doi: 10.1002/ccd.28935.
    PubMed     Abstract available


  336. SUN Y, Li J, Li G, Fan R, et al
    Impact of renin-angiotensin system inhibitors on outcomes after transcatheter aortic valve replacement: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Apr 20. doi: 10.1002/ccd.28899.
    PubMed     Abstract available


  337. BIGNOTO TC, Le Bihan D, de Mattos Barretto RB, de Oliveira Ramos AI, et al
    Predictive role of Selvester QRS score in patients undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Apr 16. doi: 10.1002/ccd.28905.
    PubMed     Abstract available


  338. YAP J, Chen S, Smith TWR, Rogers JH, et al
    Transjugular mitral valve repair with the MitraClip: A step-by-step guide.
    Catheter Cardiovasc Interv. 2020 Apr 7. doi: 10.1002/ccd.28902.
    PubMed     Abstract available


  339. UJIHIRA K, Kohmoto T, Gimelli G, Raval A, et al
    The impact of increased pulmonary arterial pressure on outcomes after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Apr 3. doi: 10.1002/ccd.28862.
    PubMed     Abstract available


  340. PERRINO C, Esposito G
    Diastolic dysfunction in severe aortic stenosis: Old but still gold.
    Catheter Cardiovasc Interv. 2020;95:1032-1033.
    PubMed     Abstract available


  341. TARANTINI G, Fabris T
    Transcatheter aortic valve replacement without previous conduction disturbances: The importance of preventing iatrogenic pacemaker implantation.
    Catheter Cardiovasc Interv. 2020;95:991-992.
    PubMed     Abstract available


  342. ARANZULLA TC, Musumeci G
    The first love, you never forget. The last heart valve, you might remember better than the first.
    Catheter Cardiovasc Interv. 2020;95:1022-1023.
    PubMed     Abstract available


  343. BUTERA G, Lucchese G, Austin C, Frigiola A, et al
    Hybrid trans-apical atrioventricular valve-in-valve implantation in Fontan circulation.
    Catheter Cardiovasc Interv. 2020;95:950-953.
    PubMed     Abstract available


  344. JONES BM, Jobanputra Y, Krishnaswamy A, Mick S, et al
    Rapid ventricular pacing during transcatheter valve procedures using an internal device and programmer: A demonstration of feasibility.
    Catheter Cardiovasc Interv. 2020;95:1042-1048.
    PubMed     Abstract available


  345. EITAN A, Brinkmann C, Haselbach T, Witt J, et al
    Does valve in valve TAVR carry a higher risk for thromboembolic events compared to native valve TAVR?
    Catheter Cardiovasc Interv. 2020;95:1017-1021.
    PubMed     Abstract available


    March 2020
  346. SCHUELER R, Ozturk C, Laser JV, Wirth F, et al
    Right ventricular assessment in patients undergoing transcatheter or surgical aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28861.
    PubMed     Abstract available


  347. WEBER M, Jaenisch M, Spilker M, Pingel S, et al
    TAVR outcome after reclassification of aortic valve stenosis by using a hybrid continuity equation that combines computed tomography and echocardiography data.
    Catheter Cardiovasc Interv. 2020 Mar 19. doi: 10.1002/ccd.28852.
    PubMed     Abstract available


  348. MAHOWALD MK, Pislaru SV, Reeder GS, Padang R, et al
    Institutional learning experience for combined edge-to-edge tricuspid and mitral valve repair.
    Catheter Cardiovasc Interv. 2020 Mar 17. doi: 10.1002/ccd.28856.
    PubMed     Abstract available


  349. MIURA M, Vicentini L, Taramasso M, Maisano F, et al
    Tangled wire in a Dacron band during Cardioband transcatheter tricuspid annuloplasty-How to solve the problem.
    Catheter Cardiovasc Interv. 2020 Mar 10. doi: 10.1002/ccd.28845.
    PubMed     Abstract available


  350. RAO SD, Jagasia D, Anwaruddin S, Birati EY, et al
    Response to: Prevention of thrombus formation following transcatheter aortic valve replacement in patients with durable left ventricular assist device.
    Catheter Cardiovasc Interv. 2020 Mar 10. doi: 10.1002/ccd.28828.
    PubMed    


  351. IMAMURA T
    Prevention of thrombus formation following transcatheter aortic valve replacement in patients with durable left ventricular assist device.
    Catheter Cardiovasc Interv. 2020 Mar 10. doi: 10.1002/ccd.28829.
    PubMed    


  352. HENSEY M, Sathananthan J, Alkhodair A, Landes U, et al
    Single-center prospective study examining use of the Wattson temporary pacing guidewire for transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Mar 9. doi: 10.1002/ccd.28832.
    PubMed     Abstract available


  353. KERN MJ, Seto AH, Ng AT, Yu JH, et al
    Effects of pericardial tamponade on the hemodynamics of aortic stenosis.
    Catheter Cardiovasc Interv. 2020 Mar 6. doi: 10.1002/ccd.28826.
    PubMed     Abstract available


  354. KHAN MZ, Khan MU, Munir MB, Khan SU, et al
    Contemporary trends and outcomes in aortic valve replacement in patients with end-stage liver disease.
    Catheter Cardiovasc Interv. 2020 Mar 4. doi: 10.1002/ccd.28834.
    PubMed     Abstract available


  355. MURDOCH DJ, Sathananthan J, Hensey M, Alu MC, et al
    Mitral regurgitation in patients undergoing transcatheter aortic valve implantation for degenerated surgical aortic bioprosthesis: Insights from PARTNER 2 Valve-in-Valve Registry.
    Catheter Cardiovasc Interv. 2020 Mar 2. doi: 10.1002/ccd.28811.
    PubMed     Abstract available


  356. TARANTINI G, Fabris T
    Pure aortic valve regurgitation: SAVR is the gold standard, but TAVR is another gun.
    Catheter Cardiovasc Interv. 2020;95:817-818.
    PubMed     Abstract available


  357. ROWIN EJ, Kimmelstiel C
    Combined alcohol septal ablation and transcatheter aortic valve replacement: Drunk and playing with fire.
    Catheter Cardiovasc Interv. 2020;95:838-839.
    PubMed     Abstract available


  358. MUSUMECI G, Aranzulla TC
    Choose to fly higher rather than pacing around.
    Catheter Cardiovasc Interv. 2020;95:791-792.
    PubMed     Abstract available


  359. RUGE H, Erlebach M, Lieberknecht E, Lange R, et al
    Successful treatment of a paravalvular leak with balloon cracking and valve-in-valve TAVR.
    Catheter Cardiovasc Interv. 2020;95:859-862.
    PubMed     Abstract available


  360. GODART F, Baudelet JB, Soquet J, Onorato E, et al
    Antegrade transcatheter closure of a dehiscence of pulmonary bioprosthesis after pulmonary valve replacement with the Occlutech paravalvular leak device.
    Catheter Cardiovasc Interv. 2020;95:855-858.
    PubMed     Abstract available


  361. EL-SABAWI B, Nishimura RA, Guerrero ME, Rihal CS, et al
    Alcohol septal ablation in patients with concomitant hypertrophic cardiomyopathy and aortic valvular stenosis.
    Catheter Cardiovasc Interv. 2020;95:830-837.
    PubMed     Abstract available


    February 2020
  362. NITA N, Scharnbeck D, Schneider LM, Seeger J, et al
    Predictors of left ventricular reverse remodeling after percutaneous therapy for mitral regurgitation with the MitraClip system.
    Catheter Cardiovasc Interv. 2020 Feb 27. doi: 10.1002/ccd.28779.
    PubMed     Abstract available


  363. POPOVIC B, Molho A, Varlot J, Fay R, et al
    Prognostic influence of acute decompensated heart failure in patients planned for transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Feb 26. doi: 10.1002/ccd.28813.
    PubMed     Abstract available


  364. DALL'ARA G, Tumscitz C, Grotti S, Santarelli A, et al
    Contemporary balloon aortic valvuloplasty: Changing indications and refined technique.
    Catheter Cardiovasc Interv. 2020 Feb 25. doi: 10.1002/ccd.28807.
    PubMed     Abstract available


  365. VEULEMANS V, Polzin A, Piayda K, Zeus T, et al
    Early restenosis of a direct flow transcatheter aortic valve prosthesis.
    Catheter Cardiovasc Interv. 2020 Feb 24. doi: 10.1002/ccd.28806.
    PubMed     Abstract available


  366. AHMED A, Alsidawi S, Bae R, Cavalcante J, et al
    Changes in quality of life in patients with low-flow aortic stenosis undergoing transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Feb 20. doi: 10.1002/ccd.28805.
    PubMed     Abstract available


  367. REIFF C, Zhingre Sanchez JD, Mattison LM, Iaizzo PA, et al
    3-Dimensional printing to predict paravalvular regurgitation after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Feb 20. doi: 10.1002/ccd.28783.
    PubMed     Abstract available


  368. OZTURK C, Fasell T, Sinning JM, Werner N, et al
    Left atrial global function in chronic heart failure patients with functional mitral regurgitation after MitraClip.
    Catheter Cardiovasc Interv. 2020 Feb 17. doi: 10.1002/ccd.28775.
    PubMed     Abstract available


  369. RAGHUNATHAN D, Garcia-Sayan E, Dhoble A, Smalling R, et al
    First-in-human report of MitraClip G4 implantation for severe degenerative mitral regurgitation.
    Catheter Cardiovasc Interv. 2020 Feb 17. doi: 10.1002/ccd.28777.
    PubMed     Abstract available


  370. TARANTINI G, Nai Fovino L
    Impella ventricular assist device: A "valvular bypass" to support high-risk percutaneous coronary intervention or complicated transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020;95:363-364.
    PubMed    


  371. SERFAS JD, Turek J, Haney J, Krasuski RA, et al
    Hybrid transcatheter pulmonary valve replacement with a SAPIEN S3 valve after pulmonary artery banding via left lateral thoracotomy.
    Catheter Cardiovasc Interv. 2020;95:E78-E83.
    PubMed     Abstract available


  372. YAP J, Chen S, Stripe BR, Smith TWR, et al
    Transseptal access for left heart structural interventions in the setting of prior atrial septal defect closure.
    Catheter Cardiovasc Interv. 2020;95:414-419.
    PubMed     Abstract available


  373. ALMALLA M, Kersten A, Altiok E, Marx N, et al
    Hemodynamic support with Impella ventricular assist device in patients undergoing TAVI: A single center experience.
    Catheter Cardiovasc Interv. 2020;95:357-362.
    PubMed     Abstract available


  374. LLOYD JW, Rihal CS, Eleid MF
    Hemodynamics rounds: Hemodynamics of mitral valve interventions.
    Catheter Cardiovasc Interv. 2020 Feb 7. doi: 10.1002/ccd.28755.
    PubMed     Abstract available


  375. ZUSMAN O, Barbash MI, Guetta V, Finkelstein A, et al
    Predicting the risk of late futile outcome after transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2020 Feb 5. doi: 10.1002/ccd.28761.
    PubMed     Abstract available


    January 2020
  376. RAO SD, Jagasia D, Anwaruddin S, Birati EY, et al
    Transcatheter aortic valve replacement thrombosis in patient supported with durable left ventricular assist device.
    Catheter Cardiovasc Interv. 2020 Jan 24. doi: 10.1002/ccd.28742.
    PubMed     Abstract available


  377. BANDYOPADHYAY D, Sartori S, Baber U, Cao D, et al
    The impact of chronic kidney disease in women undergoing transcatheter aortic valve replacement: Analysis from the Women's INternational Transcatheter Aortic Valve Implantation (WIN-TAVI) registry.
    Catheter Cardiovasc Interv. 2020 Jan 24. doi: 10.1002/ccd.28752.
    PubMed     Abstract available


  378. SHATILA W, Krajcer Z
    Transcatheter aortic valve implantation: Do leaks matter?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28684.
    PubMed    


  379. BLOCK PC, Kumar A
    Percutaneous coronary intervention with transcatheter aortic valve replacement makes no difference! None? Really?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28686.
    PubMed     Abstract available


  380. TARANTINI G, Nai Fovino L
    Treatment of aortic stenosis in patients with chronic liver disease: Another win for transfemoral TAVR?
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28690.
    PubMed     Abstract available


  381. TABACHNICK D, Obokhae B, Harrington K, Brown DL, et al
    Assessing the risk of an anomalous circumflex artery using balloon aortic valvuloplasty prior to transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28695.
    PubMed     Abstract available


  382. ZHAO ZG, Feng Y, Liao YB, Li YJ, et al
    Reshaping bicuspid aortic valve stenosis with an hourglass-shaped balloon for transcatheter aortic valve replacement: A pilot study.
    Catheter Cardiovasc Interv. 2020 Jan 14. doi: 10.1002/ccd.28726.
    PubMed     Abstract available


  383. CAMAJ A, Claessen BE, Mehran R, Yudi MB, et al
    The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO-3 trial.
    Catheter Cardiovasc Interv. 2020 Jan 13. doi: 10.1002/ccd.28717.
    PubMed     Abstract available


  384. BURZOTTA F, Aurigemma C, Romagnoli E, Shoeib O, et al
    A less-invasive totally-endovascular (LITE) technique for trans-femoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 11. doi: 10.1002/ccd.28697.
    PubMed     Abstract available


  385. NAI FOVINO L, Scotti A, Massussi M, Fabris T, et al
    Incidence and feasibility of coronary access after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28720.
    PubMed     Abstract available


  386. CAPRETTI G, Urena M, Bouleti C, Himbert D, et al
    Transcatheter tricuspid valve-in-valve replacement: Making it simpler.
    Catheter Cardiovasc Interv. 2020;95:65-67.
    PubMed     Abstract available


    December 2019
  387. KAWAGUCHI T, Yamaji K, Ishizu K, Morinaga T, et al
    Effect of postdilatation following balloon expandable transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2019 Dec 27. doi: 10.1002/ccd.28676.
    PubMed     Abstract available


  388. LIMA FV, Kolte D, Rofeberg V, Molino J, et al
    Thirty-day readmissions after transcatheter versus surgical mitral valve repair in high-risk patients with mitral regurgitation: Analysis of the 2014-2015 Nationwide readmissions databases.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28647.
    PubMed     Abstract available


  389. NAZIR S, Ahuja KR, Donato A, Grande RD, et al
    Incidence, outcomes, and predictors of in-hospital acute coronary syndrome following endovascular transcatheter aortic valve replacement in the United States.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28648.
    PubMed     Abstract available


  390. ELEID MF, Nishimura RA
    Aortic stenosis and the pulse contour: A true marker of severity?
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28674.
    PubMed     Abstract available


  391. WINKEL MG, Brugger N, Windecker S, Praz F, et al
    An unusual cause of recurrent mitral regurgitation after percutaneous mitral valve repair.
    Catheter Cardiovasc Interv. 2019 Dec 19. doi: 10.1002/ccd.28651.
    PubMed     Abstract available


  392. DUNCAN A, Mirsadree S, Quarto C, Davies S, et al
    Transcatheter aortic valve implantation 10 years after valve-in-valve transcatheter aortic valve implantation for failing aortic valve homograft root replacement.
    Catheter Cardiovasc Interv. 2019 Dec 18. doi: 10.1002/ccd.28658.
    PubMed     Abstract available


  393. BONOW RO, O'Gara PT, Adams DH, Badhwar V, et al
    MULTISOCIETY EXPERT CONSENSUS SYSTEMS OF CARE DOCUMENT 2019 AATS/ACC/SCAI/STS Expert Consensus Systems of Care Document: Operator and Institutional Recommendations and Requirements for Transcatheter Mitral Valve Intervention: A Joint Report of the Ame
    Catheter Cardiovasc Interv. 2019 Dec 16. doi: 10.1002/ccd.28671.
    PubMed     Abstract available


  394. HONDA Y, Araki M, Yamawaki M, Hirano K, et al
    The ARAHKEY technique: A novel method for the management of access site bleeding during percutaneous transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Dec 9. doi: 10.1002/ccd.28610.
    PubMed     Abstract available


  395. ALI Z, Sharma P, Mengesha T, Dalmar A, et al
    Early clinical and procedural outcomes in large series of 34-mm self-expanding transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Dec 4. doi: 10.1002/ccd.28634.
    PubMed     Abstract available


  396. SCHYMIK G, Wendler O, Hengstenberg C, Ohlmann P, et al
    Outcomes of transfemoral balloon expandable transcatheter aortic valve implantation: Comparison of two subsequent valve generations.
    Catheter Cardiovasc Interv. 2019 Dec 3. doi: 10.1002/ccd.28621.
    PubMed     Abstract available


  397. HODSON RW, Jin R, Ring ME, Gafoor S, et al
    Intrathoracic complications associated with trans-femoral transcatheter aortic valve replacement: Implications for emergency surgical preparedness.
    Catheter Cardiovasc Interv. 2019 Dec 3. doi: 10.1002/ccd.28620.
    PubMed     Abstract available


    November 2019
  398. KOTRONIAS RA, Scarsini R, De Maria GL, Rajasundaram S, et al
    Ultrasound guided vascular access site management and left ventricular pacing are associated with improved outcomes in contemporary transcatheter aortic valve replacement: Insights from the OxTAVI registry.
    Catheter Cardiovasc Interv. 2019 Nov 19. doi: 10.1002/ccd.28578.
    PubMed     Abstract available


  399. ASHLEY KE, Hillegass WB
    Clopidogrel pretreatment may reduce early acquired thrombocytopenia after transcatheter aortic valve replacement (TAVR).
    Catheter Cardiovasc Interv. 2019;94:818-819.
    PubMed     Abstract available


  400. HOLLRIEGEL R, Spindler A, Kiefer P, Woitek FJ, et al
    Outcome of patients with previous coronary artery bypass grafting and severe calcific aortic stenosis receiving transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28515.
    PubMed     Abstract available


  401. FUGAR S, Behnamfar O, Okoh AK, Alabre AF, et al
    Impact of chronic thrombocytopenia on in-hospital outcomes and healthcare resource utilization after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28519.
    PubMed     Abstract available


  402. BAZARBASHI N, Ahuja K, Gad MM, Sammour YM, et al
    The utilization of single versus double Perclose devices for transfemoral aortic valve replacement access site closure: Insights from Cleveland Clinic Aortic Valve Center.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28585.
    PubMed     Abstract available


  403. DOWLING C, Firoozi S, Panoulas V, Dalby M, et al
    Initial experience of a self-expanding transcatheter aortic valve with an outer pericardial wrap: The United Kingdom and Ireland Implanters' registry.
    Catheter Cardiovasc Interv. 2019 Nov 11. doi: 10.1002/ccd.28512.
    PubMed     Abstract available


  404. ADAMS HSL, Rajani R, Hildick-Smith D, Redwood S, et al
    "Between a rock and the mitral valve space": Transcatheter mitral valve-in-valve implantation for paravalvular leak and refractory hemolysis complicated by circumflex coronary occlusion.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28573.
    PubMed     Abstract available


  405. PATEL K, Broyd C, Chehab O, Jerrum M, et al
    Transcatheter aortic valve implantation in acute decompensated aortic stenosis.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28581.
    PubMed     Abstract available


  406. PAREKH DR, Krajcer Z
    Transapical transcatheter aortic valves. Down but definitely not out for the count.
    Catheter Cardiovasc Interv. 2019;94:745.
    PubMed    


    October 2019
  407. ELBADAWI A, Elgendy IY, Mentias A, Saad M, et al
    Outcomes of urgent versus nonurgent transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Oct 24. doi: 10.1002/ccd.28563.
    PubMed     Abstract available


  408. RAJKUMAR CA, Cook C, Shalhoub J, Chukwuemeka A, et al
    Facilitating right-sided axillary artery access for transcatheter aortic valve replacement using the Edwards Sapien 3 and ultra valves: Technical considerations.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28558.
    PubMed     Abstract available


  409. GOEL S, Pasam RT, Wats K, Patel J, et al
    Transcatheter aortic valve replacement versus surgical aortic valve replacement in low-surgical-risk patients: An updated meta-analysis.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28520.
    PubMed     Abstract available


  410. DE ROSA R, Murray MI, Schranz D, Mas-Peiro S, et al
    Short-term decrease of left atrial size predicts clinical outcome in patients with severe aortic stenosis undergoing TAVR.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28542.
    PubMed     Abstract available


  411. YEOH J, Dworakowski R, Hill J, Byrne J, et al
    A contemporary and complete treatment solution for a high-risk patient with critical aortic stenosis, left ventricular thrombus, severe left ventricular dysfunction, and calcified left main stem disease.
    Catheter Cardiovasc Interv. 2019 Oct 15. doi: 10.1002/ccd.28521.
    PubMed     Abstract available


  412. COSTA G, Buccheri S, Barbanti M, Picci A, et al
    Outcomes of three different new generation transcatheter aortic valve prostheses.
    Catheter Cardiovasc Interv. 2019 Oct 14. doi: 10.1002/ccd.28524.
    PubMed     Abstract available


  413. KUNO T, Takagi H, Sugiyama T, Ando T, et al
    Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis.
    Catheter Cardiovasc Interv. 2019 Oct 14. doi: 10.1002/ccd.28498.
    PubMed     Abstract available


  414. SINHA S, Khan A, Qureshi AM, Suh W, et al
    Application of transcatheter valves for aortic valve replacement in pediatric patients: A case series.
    Catheter Cardiovasc Interv. 2019 Oct 14. doi: 10.1002/ccd.28505.
    PubMed     Abstract available


    September 2019
  415. DOWLING C, Kondapally Seshasai SR, Firoozi S, Brecker SJ, et al
    Transcatheter aortic valve replacement versus surgery for symptomatic severe aortic stenosis: A reconstructed individual patient data meta-analysis.
    Catheter Cardiovasc Interv. 2019 Sep 30. doi: 10.1002/ccd.28504.
    PubMed     Abstract available


  416. SATHANANTHAN J, Hensey M, Sellers S, Barlow AM, et al
    Performance of the TRUE dilatation balloon valvuloplasty catheter beyond rated burst pressure: A bench study.
    Catheter Cardiovasc Interv. 2019 Sep 30. doi: 10.1002/ccd.28503.
    PubMed     Abstract available


  417. KORNOWSKI R
    Transcatheter aortic valve replacement for oncology patients with severe symptomatic aortic stenosis: New hope for a complicated medical condition.
    Catheter Cardiovasc Interv. 2019;94:446-447.
    PubMed     Abstract available


  418. CILINGIROGLU M, Margmakiolis K
    Predilatation for transcatheter aortic valve replacement: Still have a role?
    Catheter Cardiovasc Interv. 2019;94:479-480.
    PubMed     Abstract available


  419. ZAHR F, Cigarroa JE
    Replacing the mitral valve alone does not completely fix the heart!
    Catheter Cardiovasc Interv. 2019;94:467-468.
    PubMed     Abstract available


  420. MUSUMECI G, Cinconze S
    Relationship volume-outcome for transcatheter mitral-valve repair: When technique matters.
    Catheter Cardiovasc Interv. 2019;94:436-437.
    PubMed     Abstract available


    April 2019
  421. SAFI LM, Turi ZG
    A match not made in heaven-TAVR prosthesis-patient mismatch with contemporary valves.
    Catheter Cardiovasc Interv. 2019;93:980-981.
    PubMed     Abstract available


    March 2019
  422. SHATILA W, Krajcer Z
    TAVI: How to best predict postprocedural outcomes?
    Catheter Cardiovasc Interv. 2019;93:E261.
    PubMed     Abstract available


  423. GILCHRIST IC
    Treating hemolysis due to perivalvular leaks: It is all about modifying micro-jets and not the volume of regurgitation.
    Catheter Cardiovasc Interv. 2019;93:720-721.
    PubMed     Abstract available


    February 2019
  424. KIM J, Alakbarli J, Palumbo MC, Xie LX, et al
    Left ventricular geometry predicts optimal response to percutaneous mitral repair via MitraClip: Integrated assessment by two- and three-dimensional echocardiography.
    Catheter Cardiovasc Interv. 2019 Feb 21. doi: 10.1002/ccd.28147.
    PubMed     Abstract available


  425. KHAN A, Dangas G
    Positioning of self-expanding transcatheter valve prostheses.
    Catheter Cardiovasc Interv. 2019;93:530-531.
    PubMed     Abstract available


  426. SINHA S, Aboulhosn J, Asnes J, Bocks M, et al
    Initial results from the off-label use of the SAPIEN S3 valve for percutaneous transcatheter pulmonary valve replacement: A multi-institutional experience.
    Catheter Cardiovasc Interv. 2019;93:455-463.
    PubMed     Abstract available


  427. JOLLEY MA, Lasso A, Nam HH, Dinh PV, et al
    Toward predictive modeling of catheter-based pulmonary valve replacement into native right ventricular outflow tracts.
    Catheter Cardiovasc Interv. 2019;93:E143-E152.
    PubMed     Abstract available


  428. HO AB, Kaarne M, Mullen M, Hayes N, et al
    Hybrid transcatheter tricuspid valve-in-valve placement of an Edwards Sapien XT valve in palliated hypoplastic left heart syndrome.
    Catheter Cardiovasc Interv. 2019;93:481-483.
    PubMed     Abstract available


  429. MORRAY BH, Jones TK, Coe JY, Gitter R, et al
    Implantation of the Melody transcatheter pulmonary valve PB1016 in patients with dysfunctional right ventricular outflow tract conduits.
    Catheter Cardiovasc Interv. 2019;93:474-480.
    PubMed     Abstract available


  430. SHAHANAVAZ S, Rockefeller T, Nicolas R, Balzer D, et al
    Modified delivery of SAPIEN 3 valve in the pulmonary position: Evolution of technique or dire need?
    Catheter Cardiovasc Interv. 2019;93:484-487.
    PubMed     Abstract available


  431. HACHINOHE D, Latib A, Laricchia A, Demir OM, et al
    Anatomic and procedural associations of transcatheter heart valve displacement following Evolut R implantation.
    Catheter Cardiovasc Interv. 2019;93:522-529.
    PubMed     Abstract available


  432. MORGAN GJ, Sadeghi S, Salem MM, Wilson N, et al
    SAPIEN valve for percutaneous transcatheter pulmonary valve replacement without "pre-stenting": A multi-institutional experience.
    Catheter Cardiovasc Interv. 2019;93:324-329.
    PubMed     Abstract available


    January 2019
  433. ALDERWEIRELDT AS, De Wolf D
    Percutaneous closure of paravalvular leak after Cone repair for Ebstein's anomaly.
    Catheter Cardiovasc Interv. 2019;93:E46-E48.
    PubMed     Abstract available


    September 2018
  434. KESSLER M, Seeger J, Wohrle J, Rottbauer W, et al
    Intra-aortic balloon counterpulsation pump in heart failure patients during MitraClip implantation-A propensity-score matched analysis.
    Catheter Cardiovasc Interv. 2018 Sep 30. doi: 10.1002/ccd.27717.
    PubMed     Abstract available


  435. ALQAHTANI F, Ziada K, Rihal CS, Alkhouli M, et al
    Incidence and outcomes of early percutaneous coronary intervention after isolated valve surgery.
    Catheter Cardiovasc Interv. 2018 Sep 30:e27874. doi: 10.1002/ccd.27874.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: